uric acid has been researched along with Myocardial Infarction in 299 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prognostic significance of serum uric acid (SUA) in individuals who have experienced myocardial infarction (MI) remains a subject of academic debate." | 9.41 | Association of serum uric acid with prognosis in patients with myocardial infarction: an update systematic review and meta-analysis. ( Chen, X; Fang, C; Hong, C; Huang, L; Rong, J, 2023) |
| " Compared with the placebo group, the empagliflozin group showed significant decreases in body weight, systolic blood pressure, and uric acid." | 9.34 | Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. ( Asai, K; Hoshika, Y; Ishikawa, M; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Ogano, M; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K, 2020) |
| "To date uric acid (UA) is not considered a cardiovascular risk factor, although evidence about a relationship between UA and cardiovascular diseases has been reported." | 9.17 | Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction. ( Franzosi, MG; Levantesi, G; Maggioni, AP; Marchioli, R; Marfisi, RM; Nicolosi, GL; Schweiger, C; Silletta, MG; Tavazzi, L; Tognoni, G, 2013) |
| " Of 2,963 patients with coronary artery disease enrolled in the Bezafibrate Infarction Prevention study, 1,410 had MS, as established by the presence of ≥3 of the following 5 criteria: serum fasting glucose >110 mg/dl, triglycerides >150 mg/dl, high-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women, systolic and diastolic blood pressures >130 and 80 mm Hg, respectively, and body mass index >28 kg/m²." | 9.14 | Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P, 2010) |
| "In order to assess the influence of warfarin on serum urate concentration, changes in serum urate were studied in 50 patients after myocardial infarction." | 9.06 | Warfarin and uric acid after myocardial infarction. ( Arnesen, H; Smith, P, 1986) |
| "The Anturane Reinfarction Trial is a randomized, double-blind, multicenter clinical trial comparing sulfinpyrazone (200 mg four times a day) and placebo in the prevention of cardiac mortality among patients with a recent documented myocardial infarction." | 9.04 | Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. ( , 1978) |
| "To determine the validity of uric acid as a potential prognostic marker for long-term outcomes of patients with acute myocardial infarction (AMI) and those with AMI undergoing percutaneous coronary intervention (PCI)." | 8.95 | High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction. ( Abeysekera, IR; Wang, X; Xu, Q; Zhang, M, 2017) |
| "To evaluate the prognostic value of serum uric acid (SUA) in acute myocardial infarction (AMI) patients." | 8.88 | On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies. ( Car, S; Trkulja, V, 2012) |
| " Serum uric acid to albumin ratio (UAR) is a novel marker, which is associated with acute kidney injury in intensive care unit patients." | 8.31 | Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. ( Akbulut, T; Çınar, T; Şaylık, F; Selçuk, M, 2023) |
| "To determine the risk of adverse events associated with colchicine or non-steroidal anti-inflammatory drug (NSAID) prophylaxis when initiating allopurinol for gout." | 8.31 | Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. ( Bajpai, R; Clarson, LE; Forrester, H; Mallen, CD; Muller, S; Padmanabhan, N; Partington, RJ; Roddy, E; Whittle, R, 2023) |
| "To investigate the clinical value of hemoglobin to serum creatinine ratio (Hb/SCr) combined with blood uric acid (SUA) in predicting in-hospital mortality after emergency percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI)." | 8.31 | [Predictive value of hemoglobin to serum creatinine ratio combined with serum uric acid for in-hospital mortality after emergency percutaneous coronary intervention in patients with acute myocardial infarction]. ( Bao, F; Yang, C; Zhou, G, 2023) |
| "To study the associations of non-alcoholic fatty liver disease (NAFLD), chronic kidney disease (CKD), and serum uric acid (SUA) in patients with post-myocardial infarction (MI) patients, and the relationship of SUA with 12-year mortality risk." | 8.31 | Serum uric acid is related to liver and kidney disease and 12-year mortality risk after myocardial infarction. ( Boersma, E; Geleijnse, JM; Heerkens, L; Kardys, I; van Westing, AC; Voortman, T, 2023) |
| "The role of serum uric acid (SUA) in stroke remains controversial and analyses of changes in SUA and stroke are limited." | 8.12 | Effect of changes in serum uric acid on the risk of stroke and its subtypes. ( Chen, S; Luo, Y; Mo, D; Tian, X; Wang, A; Wang, Y; Wu, S; Zhang, L; Zuo, Y, 2022) |
| "Long-term patterns of serum uric acid (SUA) and their association with the risk of myocardial infarction (MI) and mortality are poorly characterized as prior studies measured SUA at a single time point." | 8.12 | High serum uric acid trajectories are associated with risk of myocardial infarction and all-cause mortality in general Chinese population. ( Chen, S; Luo, Y; Tian, X; Wang, A; Wu, S; Zuo, Y, 2022) |
| "Data on the relationship of baseline serum uric acid (SUA) with development of low-density lipoprotein cholesterol (LDL-C) level in patients with first acute myocardial infarction (AMI) are limited." | 8.02 | Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction. ( Chen, Y; Dai, C; Ding, C; Hu, L; Liao, H; Liao, Y; Ruan, Y; Xia, Y; Yang, R; Zhao, Y; Zou, K, 2021) |
| "Background Serum uric acid (SUA) has been demonstrated as a risk factor for myocardial infarction (MI) and all-cause mortality; however, the impact of cumulative SUA (cumSUA) remains unclear." | 8.02 | Cumulative Serum Uric Acid and Its Time Course Are Associated With Risk of Myocardial Infarction and All-Cause Mortality. ( Chen, S; Luo, Y; Mo, D; Tian, X; Wang, A; Wu, S; Zhang, L; Zuo, Y, 2021) |
| "To investigate the association of serum uric acid levels with in-hospital heart failure (HF) in patients with acute myocardial infarction (AMI) who are undergoing percutaneous coronary intervention (PCI)." | 8.02 | Association between Uric Acid and In-Hospital Heart Failure in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. ( Liu, CF; Song, KY; Wei, YJ; Zhou, WN, 2021) |
| "The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension conceived and designed an ad-hoc study aimed at searching for prognostic cut-off values of serum uric acid (SUA) in predicting fatal myocardial infaction (MI) in women and men." | 7.96 | Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study. ( Barbagallo, CM; Bombelli, M; Borghi, C; Bruno, B; Casiglia, E; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Desideri, G; Ferri, C; Galletti, F; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Mazza, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pontremoli, R; Quarti-Trevano, F; Rattazzi, M; Rivasi, G; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2020) |
| " Recent epidemiological and clinical evidences suggest that serum uric acid can be one of the useful markers in assessing the risk of mortality in acute myocardial infarction." | 7.96 | A Study of the Serum Uric Acid Level as Prognostic Indicator in Acute Myocardial Infarction. ( Kumar, H; Kumar, N; Kumar, V; Nayyer, PS, 2020) |
| "The role of serum uric acid (SUA) in development of myocardial infarction (MI) is controversial." | 7.96 | Associations between changes in serum uric acid and the risk of myocardial infarction. ( An, J; Chen, S; He, Y; Li, H; Luo, Y; Tian, X; Wang, A; Wu, S; Zhang, L; Zuo, Y, 2020) |
| "Whether elevated uric acid (UA) is associated with silent myocardial infarction (SMI) or whether their joint association predicts an increased risk of mortality has not been explored." | 7.91 | Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population. ( Ahmad, MI; Anees, MA; Dutta, A; Soliman, EZ, 2019) |
| "Uric acid (UA) has been associated with the presence and severity of coronary artery disease." | 7.88 | The association between uric acid levels and different clinical manifestations of coronary artery disease. ( Antonsen, S; Diederichsen, ACP; Gerke, O; Lambrechtsen, J; Larsen, TR; Mickley, H; Saaby, L; Sand, NP; Steffensen, FH, 2018) |
| "Aim To determine the relationship of homocysteine (HCY), uric acid (UA) and C-reactive protein (CRP) in serum of patients with acute myocardial infarction (AMI) prior to application of percutaneous coronary intervention (PCI) and their level of correlation in serum of patients with normal and elevated CRP (predictor of worse cardiovascular outcomes)." | 7.88 | A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction. ( Brizić, I; Čaušević, A; Jelić Knezović, N; Marković Boras, M; Mikulić, I; Vasilj, M, 2018) |
| "The present study aimed to identify a potential association between serum UA and cardiac troponin I (cTnI) levels and to find out whether uric acid could differentiate patients presenting with the acute myocardial infarction (AMI) and unstable angina pectoris (UAP) in hyperuricemic and normouricemic acute coronary syndrome (ACS) patients." | 7.85 | Serum Uric Acid Could Differentiate Acute Myocardial Infarction and Unstable Angina Pectoris in Hyperuricemic Acute Coronary Syndrome Patients. ( Hasic, S; Jadric, R; Kadic, D; Kiseljakovic, E; Spahic, E, 2017) |
| "The aim of this study was to evaluate relationships between serum uric acid (SUA) and newly emergent acute myocardial infarction (AMI), congestive heart failure (CHF), coronary artery disease (CAD), composite cardiovascular (CV) events (AMI, CHF, CAD), hypertension, hyperlipidemia, and renal disease in gout patients." | 7.85 | Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data. ( Bienen, EJ; Essex, MN; Hopps, M; Makinson, GT; Mardekian, J; Udall, M, 2017) |
| "The present study aimed to compare the serum level of uric acid in patients with and without heart failure and also to determine the association between uric acid level and clinical status by Killip class in patients with STEMI." | 7.85 | Study of Serum Uric Acid Levels in Myocardial Infarction and Its Association With Killip Class. ( Larti, F; Mehrpooya, M; Nozari, Y; Sattarzadeh-Badkoobeh, R; Shahbazi, F; Tavoosi, A; Zand Parsa, AF; Zebardast, J, 2017) |
| "Levels of C-reactive protein (CRP), uric acid (UA), and total bilirubin (TB) are associated with coronary artery disease and major adverse cardiac events (MACEs) in patients with ST-segment elevation myocardial infarction (STEMI)." | 7.83 | Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction. ( Akin, I; Baumann, S; Becher, T; Behnes, M; Borggrefe, M; Huseynov, A; Jabbour, C; Koepp, J; Lang, S; Lehmann, R; Renker, M, 2016) |
| "To quantify the risk of non-fatal acute myocardial infarction (AMI) among users of allopurinol." | 7.81 | Allopurinol use and risk of non-fatal acute myocardial infarction. ( Álvarez, A; Bryant, V; de Abajo, FJ; García-Poza, P; García-Rodríguez, LA; Gil, MJ; Rodríguez, A, 2015) |
| "This is the first large study showing that serum uric acid is not associated with an increase in the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary revascularization." | 7.80 | Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. ( Barbieri, L; De Luca, G; Di Giovine, G; Marino, P; Schaffer, A; Verdoia, M, 2014) |
| "Serum uric acid concentration is relatively stable over an eight-day post-myocardial infarction period." | 7.79 | Short-time variation in serum uric acid concentrations in post-myocardial infarction patients. ( de Sousa, C; Gonçalves, JP; Lopes, C; Maciel, MJ; Rangel, I; Severo, M, 2013) |
| "The prognostic impact of admission uric acid (UA) levels in patients with acute myocardial infarction (AMI) is controversial." | 7.79 | Uric acid in-hospital changes predict mortality in patients with acute myocardial infarction. ( Aznaouridis, K; Chrysohoou, C; Lazaros, G; Masoura, C; Patialiakas, A; Stefanadis, C; Tsiachris, D; Tsioufis, C; Vlachopoulos, C, 2013) |
| "Controversy still exists about uric acid as a potential prognostic risk factor for outcomes in patients with acute myocardial infarction." | 7.78 | Uric acid in the early risk stratification of ST-elevation myocardial infarction. ( Chiostri, M; Gensini, GF; Lazzeri, C; Picariello, C; Valente, S, 2012) |
| "In this hypothesis-generating study, gout patients who took colchicine had a significantly lower prevalence of MI and exhibited trends toward reduced all-cause mortality and lower CRP level versus those who did not take colchicine." | 7.78 | Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. ( Crittenden, DB; Cronstein, BN; Greenberg, JD; Keenan, RT; Lehmann, RA; Pillinger, MH; Schneck, L; Sedlis, SP; Shah, B, 2012) |
| " The present study reveals the protective role of ellagic acid in biochemical parameters including serum iron, plasma iron binding capacity, uric acid, glycoprotein, and electrolytes along with hematological parameters." | 7.78 | Protective efficacy of ellagic acid on glycoproteins, hematological parameters, biochemical changes, and electrolytes in myocardial infarcted rats. ( Kannan, MM; Quine, SD; Sangeetha, T, 2012) |
| "To explore the association of the uric acid levels and coronary blood flow in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI)." | 7.78 | [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention]. ( Chen, YD; Wang, CH; Wang, JW; Zhu, XL, 2012) |
| "There are limited data regarding the prognostic value of serum uric acid (UA) after acute myocardial infarction (AMI)." | 7.77 | Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction. ( Bae, MH; Chae, SC; Cho, Y; Jun, JE; Lee, JH; Lee, SH; Park, HS; Park, SH; Yang, DH, 2011) |
| " Previous studies using uric acid-lowering drugs in normouricemic animals are not suitable to answer the effect of hyperuricemia on ventricular remodeling after myocardial infarction." | 7.77 | Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia. ( Chen, CC; Hsu, YJ; Lee, TM, 2011) |
| "To study the relationship of dyslipidemia and serum uric acid with the risk of myocardial infarction among the hypertensive type 2 diabetic and non-diabetic patients of Trinidad." | 7.77 | Relationship of dyslipidemia and uric acid with the risk of myocardial infarction among hypertensive patients in Trinidad. ( Evernden, K; Fane, U; Fatt, LA; Maharaj, D; Maharaj, N; Maharaj, S; Maharaj, SS; Maharaj, V; Maloney, V; Nayak, BS, 2011) |
| " There is a possible association between ventricular dysfunction following acute myocardial infarction and high Sensitivity C-reactive protein (HS-CRP) and uric acid." | 7.77 | Correlation between the serum levels of uric acid and HS-CRP with the occurrence of early systolic failure of left ventricle following acute myocardial infarction. ( Geraiely, B; Nozari, Y, 2011) |
| "Scarce data are available on the prognostic role of uric acid (UA ) in patients with ST elevation myocardial infarction (STEMI)." | 7.76 | Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. ( Bernardo, P; Chiostri, M; Gensini, GF; Lazzeri, C; Sori, A; Valente, S, 2010) |
| " This study was designed to evaluate the protective effect of gallic acid on cardiac marker enzymes, troponin-T, LDH-isoenzyme pattern, lipid peroxidation products and antioxidant status in isoproterenol (ISO)-induced myocardial infarction in male Wistar rats." | 7.75 | Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. ( Prince, PS; Priscilla, DH, 2009) |
| " calabura), a medicinal herb, on isoproterenol-induced myocardial infarction (MI) in rat models." | 7.75 | Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction. ( Brindha, P; Jayasri, J; Nivethetha, M, 2009) |
| "Few studies have simultaneously analysed the influence of elevated serum uric acid (UA) on acute myocardial infarction (AMI), ischaemic and haemorrhagic stroke (IS, HS) and congestive heart failure (CHF) in large healthy populations." | 7.75 | Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). ( Aastveit, AH; Hammar, N; Holme, I; Jungner, I; Walldius, G, 2009) |
| "In patients with coronary artery disease (CAD), elevated serum uric acid (SUA) levels may predict worse cardiovascular outcomes." | 7.75 | Serum uric acid for risk stratification of patients with coronary artery disease. ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P; Goldenberg, I; Mandelzweig, L, 2009) |
| "To assess serum uric acid (SUA) levels determined on admission as a potential predictor of short-term mortality and long-term survival in acute myocardial infarction (AMI) patients." | 7.75 | Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study. ( Car, S; Trkulja, V, 2009) |
| "Serum uric acid concentrations are higher in patients with established coronary artery disease than in healthy controls." | 7.74 | The relationship between coronary artery disease and uric acid levels in young patients with acute myocardial infarction. ( Aktoz, M; Altun, A; Buyuklu, M; Tatli, E, 2008) |
| "Serum uric acid levels are higher in patients of acute myocardial infarction correlated with Killip class." | 7.74 | Serum uric acid in acute myocardial infarction. ( Jain, VI; Nadkar, MY, 2008) |
| "The role of uric acid as a risk factor for myocardial infarction is controversial, and little is known about its role as a risk factor for stroke." | 7.73 | Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. ( Bos, MJ; Breteler, MM; Hofman, A; Koudstaal, PJ; Witteman, JC, 2006) |
| "High serum uric acid levels have been associated with coronary heart disease (CHD)." | 7.73 | Uric acid in patients with angiographically documented coronary heart disease. ( Christensen, JH; Jespersen, JB; Larsen, A; Madsen, TV; Petersen, TS; Schmidt, EB, 2006) |
| "Comparison of the serum uric acid levels of healthy people (n=71) and patients with cardiovascular diseases (CVD) (n=62)." | 7.70 | Serum uric acid levels in cardiovascular diseases. ( Burgaz, S; Simsek, B; Torun, M; Yardim, S, 1998) |
| "Because previous findings have been inconsistent, we explored the association of serum concentrations of uric acid with all-cause and cardiovascular disease mortality and myocardial infarction prospectively." | 7.70 | Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. ( Döring, A; Hense, HW; Keil, U; Liese, AD; Löwel, H; Tietze, M, 1999) |
| "To evaluate uric acid (UA) levels in patients with postinfarction chronic cardiac failure (CCF) and to investigate correlation between accumulation of uric acid, CCF severity and some other parameters." | 7.70 | [Level of blood uric acid in patients with postinfarction heart failure]. ( Drozdov, VN; Levchuk, NN; Moiseev, VS; Tereshchenko, SN, 2000) |
| " The serum concentrations of hypoxanthine, xanthine, uric acid and allantoin were determined in peripheral blood samples from patients with angina pectoris, cerebral insult and myocardial infarction with thrombolytic therapy and were compared with the concentrations obtained for healthy males and females." | 7.69 | A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases. ( Delvoux, B; Greiling, H; Kock, R; Sigmund, M, 1994) |
| "By using a highly sensitive, high-performance liquid chromatographic technique, plasma values of malondialdehyde (MDA), adenosine and oxypurines were determined in 10 healthy subjects, 10 patients with noncardiac illness, and 20 patients with acute myocardial infarction (AMI) observed within 6 hours from the onset of symptoms." | 7.68 | Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction. ( Dagianti, A; Di Pierro, D; Fedele, F; Giardina, B; Lazzarino, G; Penco, M; Romano, S; Tavazzi, B, 1993) |
| "Serial measurements of serum uric acid were performed on patients suffering from acute myocardial infarction." | 7.66 | Critical evaluation of serum uric acid levels in acute myocardial infarction. ( Albert, A; Boland, J; Chapelle, JP; Heusghem, C; Kulbertus, HE; Smeets, JP, 1982) |
| "Hyperuricemia is independently associated with cardiovascular disease (CVD) and is considered to be one of the major risk factors for CVD." | 5.56 | Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. ( Chan, WL; Charng, MJ; Chen, JW; Chen, SC; Chen, YH; Cheng, HM; Chou, CY; Hsu, PF; Huang, CC; Huang, PH; Huang, SS; Leu, HB; Lim, SS; Lin, SJ; Lin, YJ; Lu, TM; Pan, JP; Sung, SH; Wu, CH; Wu, TC; Yang, YL, 2020) |
| "Allopurinol is a urate-lowering therapy used to treat patients with gout." | 5.51 | Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. ( Avery, AJ; Barr, RJ; Begg, AG; Duce, SL; Dumbleton, JS; Ford, I; Greenlaw, N; Hawkey, CJ; MacDonald, TM; Mackenzie, IS; Pigazzani, F; Ritchie, LD; Rogers, A; Rooke, ED; Struthers, AD; Taggar, JS; Townend, JN; Walker, A; Wei, L, 2022) |
| "1." | 5.46 | Mechanism-based pharmacokinetic-pharmacodynamic modeling of salvianolic acid A effects on plasma xanthine oxidase activity and uric acid levels in acute myocardial infarction rats. ( He, H; Li, X; Liu, X; Liu, Y; Wang, H; Wang, S; Zhang, W, 2017) |
| "The prognostic significance of serum uric acid (SUA) in individuals who have experienced myocardial infarction (MI) remains a subject of academic debate." | 5.41 | Association of serum uric acid with prognosis in patients with myocardial infarction: an update systematic review and meta-analysis. ( Chen, X; Fang, C; Hong, C; Huang, L; Rong, J, 2023) |
| "Uric acid (UA) is a strong marker of cardiovascular disease." | 5.40 | The association between serum uric acid level and heart failure and mortality in the early period of ST-elevation acute myocardial infarction. ( Altun, B; Barutçu, A; Bekler, A; Gazi, E; Gazi, S; Güngör, O; Kurt, T; Ozcan, S; Temiz, A; Yener, AU, 2014) |
| " Compared with the placebo group, the empagliflozin group showed significant decreases in body weight, systolic blood pressure, and uric acid." | 5.34 | Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. ( Asai, K; Hoshika, Y; Ishikawa, M; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Ogano, M; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K, 2020) |
| "Hyperuricemia has been identified in patients who have congestive heart failure and is a marker of poor prognosis in such patients." | 5.33 | Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). ( Hiraoka, H; Honda, T; Ishihara, M; Kimura, K; Kojima, S; Matsui, K; Miyazaki, S; Ogata, Y; Ogawa, H; Sakamoto, T; Shimoyama, N; Sonoda, M; Tei, C; Tsuchihashi, K; Yamagishi, M, 2005) |
| "To date uric acid (UA) is not considered a cardiovascular risk factor, although evidence about a relationship between UA and cardiovascular diseases has been reported." | 5.17 | Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction. ( Franzosi, MG; Levantesi, G; Maggioni, AP; Marchioli, R; Marfisi, RM; Nicolosi, GL; Schweiger, C; Silletta, MG; Tavazzi, L; Tognoni, G, 2013) |
| " Of 2,963 patients with coronary artery disease enrolled in the Bezafibrate Infarction Prevention study, 1,410 had MS, as established by the presence of ≥3 of the following 5 criteria: serum fasting glucose >110 mg/dl, triglycerides >150 mg/dl, high-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women, systolic and diastolic blood pressures >130 and 80 mm Hg, respectively, and body mass index >28 kg/m²." | 5.14 | Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P, 2010) |
| " A randomized trial was carried out in 30 young patients with recent acute myocardial infarction (AMI) and high plasma homocysteine concentrations." | 5.11 | Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients. ( Albertini, F; Archetti, S; Assanelli, D; Bonanome, A; Grassi, M; Maccalli, P; Negrini, R; Pezzini, A; Visioli, F, 2004) |
| "To examine the relationship between raised serum uric acid and subsequent cardiovascular events (mortality, myocardial infarction, stroke)." | 5.09 | Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans? ( Longo-Mbenza, B; Luila, EL; Mbete, P; Vita, EK, 1999) |
| " The aim of this work was to study the relationship between the Cortisol blood level and the intensity of free radical reactions in patients with acute myocardial ischemia and acute myocardial infarction with respect to metabolic (glucose, uric acid) and enzymatic agents of ischemia and necrosis." | 5.09 | [Cortisol levels in blood of persons with acute myocardial ischemia and myocardial infarction]. ( Domański, L, 1999) |
| "In order to assess the influence of warfarin on serum urate concentration, changes in serum urate were studied in 50 patients after myocardial infarction." | 5.06 | Warfarin and uric acid after myocardial infarction. ( Arnesen, H; Smith, P, 1986) |
| "The efficacy and safety of a combination of Persantine and aspirin, of aspirin alone and of a placebo as a regimen for preventing reinfarction were compared in 2026 patients who had recovered from a documented acute myocardial infarction (MI) that had occurred 8 weeks to 5 years previously." | 5.05 | The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group. ( , 1980) |
| "The Anturane Reinfarction Trial is a randomized, double-blind, multicenter clinical trial comparing sulfinpyrazone (200 mg four times a day) and placebo in the prevention of cardiac mortality among patients with a recent documented myocardial infarction." | 5.04 | Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. ( , 1978) |
| "To determine the validity of uric acid as a potential prognostic marker for long-term outcomes of patients with acute myocardial infarction (AMI) and those with AMI undergoing percutaneous coronary intervention (PCI)." | 4.95 | High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction. ( Abeysekera, IR; Wang, X; Xu, Q; Zhang, M, 2017) |
| "To evaluate the prognostic value of serum uric acid (SUA) in acute myocardial infarction (AMI) patients." | 4.88 | On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies. ( Car, S; Trkulja, V, 2012) |
| " Serum uric acid to albumin ratio (UAR) is a novel marker, which is associated with acute kidney injury in intensive care unit patients." | 4.31 | Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. ( Akbulut, T; Çınar, T; Şaylık, F; Selçuk, M, 2023) |
| "The association between serum creatine phosphokinase (CPK), a standard biochemical measure of acute myocardial infarction, and serum uric acid (sUA) has not been studied." | 4.31 | The association between serum uric acid and creatine phosphokinase in the general population: NHANES 2015-2018. ( Chen, X; Huang, C; Ma, H; You, J; Zhou, M, 2023) |
| "To determine the risk of adverse events associated with colchicine or non-steroidal anti-inflammatory drug (NSAID) prophylaxis when initiating allopurinol for gout." | 4.31 | Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. ( Bajpai, R; Clarson, LE; Forrester, H; Mallen, CD; Muller, S; Padmanabhan, N; Partington, RJ; Roddy, E; Whittle, R, 2023) |
| "To investigate the clinical value of hemoglobin to serum creatinine ratio (Hb/SCr) combined with blood uric acid (SUA) in predicting in-hospital mortality after emergency percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI)." | 4.31 | [Predictive value of hemoglobin to serum creatinine ratio combined with serum uric acid for in-hospital mortality after emergency percutaneous coronary intervention in patients with acute myocardial infarction]. ( Bao, F; Yang, C; Zhou, G, 2023) |
| "To study the associations of non-alcoholic fatty liver disease (NAFLD), chronic kidney disease (CKD), and serum uric acid (SUA) in patients with post-myocardial infarction (MI) patients, and the relationship of SUA with 12-year mortality risk." | 4.31 | Serum uric acid is related to liver and kidney disease and 12-year mortality risk after myocardial infarction. ( Boersma, E; Geleijnse, JM; Heerkens, L; Kardys, I; van Westing, AC; Voortman, T, 2023) |
| "The role of serum uric acid (SUA) in stroke remains controversial and analyses of changes in SUA and stroke are limited." | 4.12 | Effect of changes in serum uric acid on the risk of stroke and its subtypes. ( Chen, S; Luo, Y; Mo, D; Tian, X; Wang, A; Wang, Y; Wu, S; Zhang, L; Zuo, Y, 2022) |
| "Hyperuricemia is widely thought as a risk factor for myocardial infarction (MI) and all-cause mortality; however, the relation of serum uric acid (sUA) and subclinical myocardial injury (SCeMI) remains unclear." | 4.12 | Impact of serum uric acid on subclinical myocardial injury in general population. ( Chen, S; Huang, Y; Li, Z; Lin, W; Lin, Z; Wang, F; Yan, L; Yang, X; Zhang, L, 2022) |
| "Although serum uric acid (UA) is considered as a risk factor for cardiovascular disease, few data exist regarding the relationship between hyperuricemia, coronary blood flow, and subsequent outcome in patients with acute myocardial infarction (AMI)." | 4.12 | Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention. ( Dohi, K; Hanada, H; Higuma, T; Kumagai, N; Masuda, J; Nakahashi, T; Nakamura, M; Ogimoto, A; Sakata, K; Takamura, M; Tanigawa, T, 2022) |
| "Long-term patterns of serum uric acid (SUA) and their association with the risk of myocardial infarction (MI) and mortality are poorly characterized as prior studies measured SUA at a single time point." | 4.12 | High serum uric acid trajectories are associated with risk of myocardial infarction and all-cause mortality in general Chinese population. ( Chen, S; Luo, Y; Tian, X; Wang, A; Wu, S; Zuo, Y, 2022) |
| "Data on the relationship of baseline serum uric acid (SUA) with development of low-density lipoprotein cholesterol (LDL-C) level in patients with first acute myocardial infarction (AMI) are limited." | 4.02 | Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction. ( Chen, Y; Dai, C; Ding, C; Hu, L; Liao, H; Liao, Y; Ruan, Y; Xia, Y; Yang, R; Zhao, Y; Zou, K, 2021) |
| "Background Serum uric acid (SUA) has been demonstrated as a risk factor for myocardial infarction (MI) and all-cause mortality; however, the impact of cumulative SUA (cumSUA) remains unclear." | 4.02 | Cumulative Serum Uric Acid and Its Time Course Are Associated With Risk of Myocardial Infarction and All-Cause Mortality. ( Chen, S; Luo, Y; Mo, D; Tian, X; Wang, A; Wu, S; Zhang, L; Zuo, Y, 2021) |
| "To investigate the association of serum uric acid levels with in-hospital heart failure (HF) in patients with acute myocardial infarction (AMI) who are undergoing percutaneous coronary intervention (PCI)." | 4.02 | Association between Uric Acid and In-Hospital Heart Failure in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. ( Liu, CF; Song, KY; Wei, YJ; Zhou, WN, 2021) |
| "The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension conceived and designed an ad-hoc study aimed at searching for prognostic cut-off values of serum uric acid (SUA) in predicting fatal myocardial infaction (MI) in women and men." | 3.96 | Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study. ( Barbagallo, CM; Bombelli, M; Borghi, C; Bruno, B; Casiglia, E; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Desideri, G; Ferri, C; Galletti, F; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Mazza, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pontremoli, R; Quarti-Trevano, F; Rattazzi, M; Rivasi, G; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2020) |
| " Recent epidemiological and clinical evidences suggest that serum uric acid can be one of the useful markers in assessing the risk of mortality in acute myocardial infarction." | 3.96 | A Study of the Serum Uric Acid Level as Prognostic Indicator in Acute Myocardial Infarction. ( Kumar, H; Kumar, N; Kumar, V; Nayyer, PS, 2020) |
| "The role of serum uric acid (SUA) in development of myocardial infarction (MI) is controversial." | 3.96 | Associations between changes in serum uric acid and the risk of myocardial infarction. ( An, J; Chen, S; He, Y; Li, H; Luo, Y; Tian, X; Wang, A; Wu, S; Zhang, L; Zuo, Y, 2020) |
| "Whether elevated uric acid (UA) is associated with silent myocardial infarction (SMI) or whether their joint association predicts an increased risk of mortality has not been explored." | 3.91 | Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population. ( Ahmad, MI; Anees, MA; Dutta, A; Soliman, EZ, 2019) |
| "Uric acid (UA) has been associated with the presence and severity of coronary artery disease." | 3.88 | The association between uric acid levels and different clinical manifestations of coronary artery disease. ( Antonsen, S; Diederichsen, ACP; Gerke, O; Lambrechtsen, J; Larsen, TR; Mickley, H; Saaby, L; Sand, NP; Steffensen, FH, 2018) |
| "Aim To determine the relationship of homocysteine (HCY), uric acid (UA) and C-reactive protein (CRP) in serum of patients with acute myocardial infarction (AMI) prior to application of percutaneous coronary intervention (PCI) and their level of correlation in serum of patients with normal and elevated CRP (predictor of worse cardiovascular outcomes)." | 3.88 | A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction. ( Brizić, I; Čaušević, A; Jelić Knezović, N; Marković Boras, M; Mikulić, I; Vasilj, M, 2018) |
| "The present study aimed to identify a potential association between serum UA and cardiac troponin I (cTnI) levels and to find out whether uric acid could differentiate patients presenting with the acute myocardial infarction (AMI) and unstable angina pectoris (UAP) in hyperuricemic and normouricemic acute coronary syndrome (ACS) patients." | 3.85 | Serum Uric Acid Could Differentiate Acute Myocardial Infarction and Unstable Angina Pectoris in Hyperuricemic Acute Coronary Syndrome Patients. ( Hasic, S; Jadric, R; Kadic, D; Kiseljakovic, E; Spahic, E, 2017) |
| " Cox regression analysis showed that the baseline clinical and biochemical variables which associated with MACE were age, being illiterate, a widow or widower, and/or economically dependent, having triple vessel disease, stent implantation, anemia, and/or diabetes mellitus, waist to hip ratio (WHR), diastolic blood pressure, fasting glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), creatinine, estimated glomerular filtration rate (eGFR), red blood cell count, hemoglobin, hematocrit, and mean corpuscular-hemoglobin concentration (MCHC) in ACS patients, and age, malnourished, and/or economically dependent, taking hypoglycemic medication, having triple vessel disease, stent implantation, anemia, diabetes mellitus, and/or hypertension, WHR, fasting glucose, HDL-C, uric acid, creatinine, eGFR, high-sensitivity C-reactive protein, mean corpuscular volume, and MCHC in elective PCI patients." | 3.85 | The burden of major adverse cardiac events in patients with coronary artery disease. ( Chung, FM; Hsu, CC; Hung, WC; Lee, YJ; Lu, LF; Lu, YC; Tsai, IT; Wang, CP; Wu, CC; Yu, TH, 2017) |
| "The aim of this study was to evaluate relationships between serum uric acid (SUA) and newly emergent acute myocardial infarction (AMI), congestive heart failure (CHF), coronary artery disease (CAD), composite cardiovascular (CV) events (AMI, CHF, CAD), hypertension, hyperlipidemia, and renal disease in gout patients." | 3.85 | Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data. ( Bienen, EJ; Essex, MN; Hopps, M; Makinson, GT; Mardekian, J; Udall, M, 2017) |
| "The present study aimed to compare the serum level of uric acid in patients with and without heart failure and also to determine the association between uric acid level and clinical status by Killip class in patients with STEMI." | 3.85 | Study of Serum Uric Acid Levels in Myocardial Infarction and Its Association With Killip Class. ( Larti, F; Mehrpooya, M; Nozari, Y; Sattarzadeh-Badkoobeh, R; Shahbazi, F; Tavoosi, A; Zand Parsa, AF; Zebardast, J, 2017) |
| "Levels of C-reactive protein (CRP), uric acid (UA), and total bilirubin (TB) are associated with coronary artery disease and major adverse cardiac events (MACEs) in patients with ST-segment elevation myocardial infarction (STEMI)." | 3.83 | Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction. ( Akin, I; Baumann, S; Becher, T; Behnes, M; Borggrefe, M; Huseynov, A; Jabbour, C; Koepp, J; Lang, S; Lehmann, R; Renker, M, 2016) |
| "To assess gender differences in uric acid (UA) as predictor for hard events (HE, mortality and nonfatal myocardial infarction) in a large cohort of patients referred for coronary angiography." | 3.83 | Gender differences for uric acid as predictor of hard events in patients referred for coronary angiography. ( Arvia, C; Battaglia, D; Carpeggiani, C; Chatzianagnostou, K; Guiducci, L; Landi, P; Maffei, S; Vannucci, A; Vassalle, C, 2016) |
| " After adjustment of age, gender, education level, income, drink, history of myocardial infarction, history of stroke, serum uric acid and C reactive protein level, multiple Cox regression analysis showed that one health score point increase was related to 8% reduction of new onset atrial fibrillation(HR=0." | 3.83 | [Association between the cardiovascular health score and new-onset atrial fibrillation]. ( Ji, CP; Shi, JH; Wang, YZ; Wei, XM; Wu, SL; Xing, AJ; Zhu, CR, 2016) |
| "We evaluated uric acid (UA) and high-sensitivity C-reactive protein (hs-CRP) levels in different clinical types of acute coronary syndromes (ACS) and in relationship with the severity of coronary artery lesions." | 3.83 | Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion. ( Fu, Q; Li, XD; Liu, L; Ma, QQ; Wei, P; Yang, NQ; Yang, XJ; Zhu, K, 2016) |
| "To quantify the risk of non-fatal acute myocardial infarction (AMI) among users of allopurinol." | 3.81 | Allopurinol use and risk of non-fatal acute myocardial infarction. ( Álvarez, A; Bryant, V; de Abajo, FJ; García-Poza, P; García-Rodríguez, LA; Gil, MJ; Rodríguez, A, 2015) |
| "Over a 20-year period, patients on dapagliflozin were projected to experience relative reductions in the incidence of myocardial infarction (MI), stroke, CV death, and all-cause death of 13." | 3.80 | Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes. ( Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J, 2014) |
| "This is the first large study showing that serum uric acid is not associated with an increase in the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary revascularization." | 3.80 | Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. ( Barbieri, L; De Luca, G; Di Giovine, G; Marino, P; Schaffer, A; Verdoia, M, 2014) |
| "We assessed the relationship between contrast-induced nephropathy (CIN) and SYNTAX score (SS) and serum uric acid (SUA) levels in patients with ST elevation myocardial infarction (STEMI)." | 3.80 | Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. ( Çayli, M; Elbasan, Z; Gür, M; Içen, YK; Kivrak, A; Kuloğlu, O; Özdogru, I; Şahin, DY; Türkoglu, C; Yildirim, A, 2014) |
| "Serum uric acid concentration is relatively stable over an eight-day post-myocardial infarction period." | 3.79 | Short-time variation in serum uric acid concentrations in post-myocardial infarction patients. ( de Sousa, C; Gonçalves, JP; Lopes, C; Maciel, MJ; Rangel, I; Severo, M, 2013) |
| "The prognostic impact of admission uric acid (UA) levels in patients with acute myocardial infarction (AMI) is controversial." | 3.79 | Uric acid in-hospital changes predict mortality in patients with acute myocardial infarction. ( Aznaouridis, K; Chrysohoou, C; Lazaros, G; Masoura, C; Patialiakas, A; Stefanadis, C; Tsiachris, D; Tsioufis, C; Vlachopoulos, C, 2013) |
| "Controversy still exists about uric acid as a potential prognostic risk factor for outcomes in patients with acute myocardial infarction." | 3.78 | Uric acid in the early risk stratification of ST-elevation myocardial infarction. ( Chiostri, M; Gensini, GF; Lazzeri, C; Picariello, C; Valente, S, 2012) |
| "These were post hoc analyses of datasets from the Aspirin Myocardial Infarction Study, a 1:1 randomized, double-blind clinical trial, conducted from 1975 to 1979, that examined mortality rates following daily aspirin administration over three years in individuals with documented MI." | 3.78 | Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. ( Dabbous, O; Hariri, A; Krishnan, E; Lingala, B; Pandya, BJ, 2012) |
| "In this hypothesis-generating study, gout patients who took colchicine had a significantly lower prevalence of MI and exhibited trends toward reduced all-cause mortality and lower CRP level versus those who did not take colchicine." | 3.78 | Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. ( Crittenden, DB; Cronstein, BN; Greenberg, JD; Keenan, RT; Lehmann, RA; Pillinger, MH; Schneck, L; Sedlis, SP; Shah, B, 2012) |
| " The present study reveals the protective role of ellagic acid in biochemical parameters including serum iron, plasma iron binding capacity, uric acid, glycoprotein, and electrolytes along with hematological parameters." | 3.78 | Protective efficacy of ellagic acid on glycoproteins, hematological parameters, biochemical changes, and electrolytes in myocardial infarcted rats. ( Kannan, MM; Quine, SD; Sangeetha, T, 2012) |
| "To explore the association of the uric acid levels and coronary blood flow in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI)." | 3.78 | [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention]. ( Chen, YD; Wang, CH; Wang, JW; Zhu, XL, 2012) |
| "There is significant controversy around whether chlorthalidone (CTD) is superior to hydrochlorothiazide (HCTZ) in hypertension management." | 3.77 | Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. ( Bleske, BE; Dorsch, MP; Erickson, SR; Gillespie, BW; Weder, AB, 2011) |
| "There are limited data regarding the prognostic value of serum uric acid (UA) after acute myocardial infarction (AMI)." | 3.77 | Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction. ( Bae, MH; Chae, SC; Cho, Y; Jun, JE; Lee, JH; Lee, SH; Park, HS; Park, SH; Yang, DH, 2011) |
| " Previous studies using uric acid-lowering drugs in normouricemic animals are not suitable to answer the effect of hyperuricemia on ventricular remodeling after myocardial infarction." | 3.77 | Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia. ( Chen, CC; Hsu, YJ; Lee, TM, 2011) |
| "This short-term prospective study included 40 patients with acute myocardial infarction (AMI) in whom we determined GGT activity, lipids, uric acid, homocysteine (Hcy), high sensitivity C-reactive protein (hsCRP) and left ventricular (LV) function on admission and on day 5 following AMI." | 3.77 | Is γ-glutamyl transferase activity a potential marker of left ventricular function during early postmyocardial infarction period? ( Dzubur, A; Hadzovic-Dzuvo, A; Jadric, R; Kiseljakovic, E; Lepara, O; Nakas-Icindic, E; Valjevac, A, 2011) |
| "To study the relationship of dyslipidemia and serum uric acid with the risk of myocardial infarction among the hypertensive type 2 diabetic and non-diabetic patients of Trinidad." | 3.77 | Relationship of dyslipidemia and uric acid with the risk of myocardial infarction among hypertensive patients in Trinidad. ( Evernden, K; Fane, U; Fatt, LA; Maharaj, D; Maharaj, N; Maharaj, S; Maharaj, SS; Maharaj, V; Maloney, V; Nayak, BS, 2011) |
| " There is a possible association between ventricular dysfunction following acute myocardial infarction and high Sensitivity C-reactive protein (HS-CRP) and uric acid." | 3.77 | Correlation between the serum levels of uric acid and HS-CRP with the occurrence of early systolic failure of left ventricle following acute myocardial infarction. ( Geraiely, B; Nozari, Y, 2011) |
| "Scarce data are available on the prognostic role of uric acid (UA ) in patients with ST elevation myocardial infarction (STEMI)." | 3.76 | Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. ( Bernardo, P; Chiostri, M; Gensini, GF; Lazzeri, C; Sori, A; Valente, S, 2010) |
| " This study was designed to evaluate the protective effect of gallic acid on cardiac marker enzymes, troponin-T, LDH-isoenzyme pattern, lipid peroxidation products and antioxidant status in isoproterenol (ISO)-induced myocardial infarction in male Wistar rats." | 3.75 | Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. ( Prince, PS; Priscilla, DH, 2009) |
| " calabura), a medicinal herb, on isoproterenol-induced myocardial infarction (MI) in rat models." | 3.75 | Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction. ( Brindha, P; Jayasri, J; Nivethetha, M, 2009) |
| "Few studies have simultaneously analysed the influence of elevated serum uric acid (UA) on acute myocardial infarction (AMI), ischaemic and haemorrhagic stroke (IS, HS) and congestive heart failure (CHF) in large healthy populations." | 3.75 | Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). ( Aastveit, AH; Hammar, N; Holme, I; Jungner, I; Walldius, G, 2009) |
| "In patients with coronary artery disease (CAD), elevated serum uric acid (SUA) levels may predict worse cardiovascular outcomes." | 3.75 | Serum uric acid for risk stratification of patients with coronary artery disease. ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P; Goldenberg, I; Mandelzweig, L, 2009) |
| "To assess serum uric acid (SUA) levels determined on admission as a potential predictor of short-term mortality and long-term survival in acute myocardial infarction (AMI) patients." | 3.75 | Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study. ( Car, S; Trkulja, V, 2009) |
| "Serum uric acid concentrations are higher in patients with established coronary artery disease than in healthy controls." | 3.74 | The relationship between coronary artery disease and uric acid levels in young patients with acute myocardial infarction. ( Aktoz, M; Altun, A; Buyuklu, M; Tatli, E, 2008) |
| "This study was aimed to evaluate the preventive role of S-allylcysteine (SAC) on creatine kinase-MB, iron, iron binding capacity, uric acid, total protein, membrane-bound enzymes such as sodium potassium-dependent adenosine triphosphatase, calcium-dependent adenosine triphosphatase and magnesium-dependent adenosine triphosphatase, and glycoproteins such as hexose, hexosamine, fucose and sialic acid in isoproterenol-induced myocardial infarction in rats." | 3.74 | Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats. ( Padmanabhan, M; Prince, PS; Rajadurai, M, 2008) |
| "Serum uric acid levels are higher in patients of acute myocardial infarction correlated with Killip class." | 3.74 | Serum uric acid in acute myocardial infarction. ( Jain, VI; Nadkar, MY, 2008) |
| "This study was aimed to evaluate the preventive role of naringin on heart weight, blood glucose, total proteins, albumin/globulin (A/G) ratio, serum uric acid, serum iron, plasma iron binding capacity and membrane bound enzymes such as sodium potassium-dependent adenosine triphosphatase (Na(+)/K(+) ATPase), calcium-dependent adenosine triphosphatase (Ca(2+) ATPase) and magnesium-dependent adenosine triphosphatase (Mg(2+) ATPase) and glycoproteins such as hexose, hexosamine, fucose and sialic acid in isoproterenol (ISO)-induced myocardial infarction (MI) in rats and in vitro free radical scavenging assay." | 3.74 | Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. ( Prince, PS; Rajadurai, M, 2007) |
| "The role of uric acid as a risk factor for myocardial infarction is controversial, and little is known about its role as a risk factor for stroke." | 3.73 | Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. ( Bos, MJ; Breteler, MM; Hofman, A; Koudstaal, PJ; Witteman, JC, 2006) |
| "High serum uric acid levels have been associated with coronary heart disease (CHD)." | 3.73 | Uric acid in patients with angiographically documented coronary heart disease. ( Christensen, JH; Jespersen, JB; Larsen, A; Madsen, TV; Petersen, TS; Schmidt, EB, 2006) |
| "Comparison of the serum uric acid levels of healthy people (n=71) and patients with cardiovascular diseases (CVD) (n=62)." | 3.70 | Serum uric acid levels in cardiovascular diseases. ( Burgaz, S; Simsek, B; Torun, M; Yardim, S, 1998) |
| "Because previous findings have been inconsistent, we explored the association of serum concentrations of uric acid with all-cause and cardiovascular disease mortality and myocardial infarction prospectively." | 3.70 | Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. ( Döring, A; Hense, HW; Keil, U; Liese, AD; Löwel, H; Tietze, M, 1999) |
| "To evaluate uric acid (UA) levels in patients with postinfarction chronic cardiac failure (CCF) and to investigate correlation between accumulation of uric acid, CCF severity and some other parameters." | 3.70 | [Level of blood uric acid in patients with postinfarction heart failure]. ( Drozdov, VN; Levchuk, NN; Moiseev, VS; Tereshchenko, SN, 2000) |
| " The serum concentrations of hypoxanthine, xanthine, uric acid and allantoin were determined in peripheral blood samples from patients with angina pectoris, cerebral insult and myocardial infarction with thrombolytic therapy and were compared with the concentrations obtained for healthy males and females." | 3.69 | A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases. ( Delvoux, B; Greiling, H; Kock, R; Sigmund, M, 1994) |
| "Serum total antioxidant activity (TAA), albumin and uric acid were measured on admission, and for the next 2 days in 56 patients suffering myocardial infarction, 20 of whom received streptokinase." | 3.69 | Serum total antioxidant activity after myocardial infarction. ( Collis, CS; Johnston, JD; Miller, NJ; Rice-Evans, C, 1997) |
| " Body mass index (BMI), waist/hip ratio (WHR), blood pressure (BP); oral glucose tolerance test (OGTT) with measurement of serum glucose, insulin and C-peptide every 30 min for 2 h, fasting serum cholesterol, triglycerides and uric acid, areas under curve (AUC) of glucose and insulin, insulin/glucose ratio and insulin sensitivity index were calculated." | 3.69 | Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors. ( Almazán, A; Ariza, CR; Frati, AC; Gómez, G, 1997) |
| "Amongst 86 patients with myocardial infarction, during their stay in a rehabilitation clinic, emotions (Gottschalk-Gleser speech content analysis), assessed at the beginning of the treatment, and cardiovascular (systolic and diastolic blood pressure, heart rate and reactivity during physical stress, performance) and metabolic parameters (triglycerides, HDL- and LDL-cholesterin, cholesterin/HDL, uric acid) assessed at the beginning (concurrent) and end (predictive) of the treatment, are examined." | 3.68 | [Concurrent and predictive correlations between emotions and cardiovascular and metabolic parameters in patients with myocardial infarct]. ( Bartram, M; Hardinghaus, W; Rogner, J; Wirth, A, 1993) |
| "By using a highly sensitive, high-performance liquid chromatographic technique, plasma values of malondialdehyde (MDA), adenosine and oxypurines were determined in 10 healthy subjects, 10 patients with noncardiac illness, and 20 patients with acute myocardial infarction (AMI) observed within 6 hours from the onset of symptoms." | 3.68 | Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction. ( Dagianti, A; Di Pierro, D; Fedele, F; Giardina, B; Lazzarino, G; Penco, M; Romano, S; Tavazzi, B, 1993) |
| "In a prospective study 32 patients with condition after acute myocardial infarction in the rehabilitation phase II were observed concerning the metabolic parameters, beta-lipoproteins, cholesterol, triglycerides, glucose, uric acid and lactate." | 3.67 | [Changes in the metabolic parameters in patients with acute myocardial infarct in the course of the rehabilitation phase II]. ( Dietel, M; Kirchner, C; Scheibe, J; Thiele, R, 1985) |
| "Baseline white blood cell count (WCC) and haematocrit were examined in relation to recurrent coronary events and to all-cause mortality in 2026 persons enrolled in the first Persantin-Aspirin Reinfarction Study (PARIS-1) 2-60 months after myocardial infarction." | 3.67 | White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. ( Barton, BA; Forbes, CD; Krol, WF; Lowe, GD; Machado, SG, 1985) |
| "Serial measurements of serum uric acid were performed on patients suffering from acute myocardial infarction." | 3.66 | Critical evaluation of serum uric acid levels in acute myocardial infarction. ( Albert, A; Boland, J; Chapelle, JP; Heusghem, C; Kulbertus, HE; Smeets, JP, 1982) |
| " Regression analysis revealed statistically significant changes of systolic and diastolic blood pressures, fasting blood glucose, serum cholesterol, serum triglycerides and serum uric acid with changes in body weight." | 3.66 | Body weight change in relation to incidence of ischemic heart disease and change in risk factors for ischemic heart disease. ( Noppa, H, 1980) |
| "Plasma urate, urea and creatinine were measured at daily intervals for up to six days in 22 patients suffering from acute myocardial infarction." | 3.65 | Uraemia and hyperuricaemia in acute myocardial infarction. ( Wiener, K, 1976) |
| "The etiology of hyperuricemia following myocardial infarction was investigated by uric acid kinetic studies carried out on seven male patients following myocardial infarction and on two control subjects." | 3.65 | Uric acid kinetic studies in the immediate post-myocardial-infarction period. ( Crawhall, JC; Dosman, JA; Klassen, GA, 1975) |
| "Acute kidney injury is a frequent complication among ST segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI), and is associated with adverse outcomes." | 2.53 | Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity. ( Arbel, Y; Shacham, Y; Steinvil, A, 2016) |
| "The prognosis of unstable angina pectoris (UAP) differs from non-ST-segment elevation myocardial infarction, and percutaneous coronary intervention (PCI) is considered to improve outcomes of UAP." | 1.72 | The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention. ( Chen, H; Cui, H; Li, H; Li, S; Liang, S; Zhou, L, 2022) |
| "This study was to investigate the correlation between glycated haemoglobin (HbA1c) level, cardiac function, and prognosis in patients with diabetes mellitus combined with myocardial infarction." | 1.72 | Correlation between Glycated Haemoglobin Level, Cardiac Function, and Prognosis in Patients with Diabetes Mellitus Combined with Myocardial Infarction. ( An, H; Fang, D; Li, W; Sun, M; Zeng, G; Zheng, Q, 2022) |
| "Vitamin D deficiency has been shown to be associated with coronary artery disease (CAD)." | 1.56 | The relationship between a combination of vitamin D deficiency and hyperuricemia and the severity of coronary artery disease in myocardial infarction patients. ( Akgül, F; Akgün, T; Çakır, MO; Can, M; Serbest, NG; Somuncu, MU; Tatar, FP; Tekin, A, 2020) |
| "Hyperuricemia is independently associated with cardiovascular disease (CVD) and is considered to be one of the major risk factors for CVD." | 1.56 | Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention. ( Chan, WL; Charng, MJ; Chen, JW; Chen, SC; Chen, YH; Cheng, HM; Chou, CY; Hsu, PF; Huang, CC; Huang, PH; Huang, SS; Leu, HB; Lim, SS; Lin, SJ; Lin, YJ; Lu, TM; Pan, JP; Sung, SH; Wu, CH; Wu, TC; Yang, YL, 2020) |
| "Low uric acid level might cause adverse outcomes in VSA in connection with endothelial dysfunction." | 1.46 | Uric Acid Level Has a U-shaped Association with Clinical Outcomes in Patients with Vasospastic Angina. ( Choi, JH; Choi, SH; Gwag, HB; Gwon, HC; Hahn, JY; Lee, SH; Park, TK; Song, YB; Yang, JH, 2017) |
| "1." | 1.46 | Mechanism-based pharmacokinetic-pharmacodynamic modeling of salvianolic acid A effects on plasma xanthine oxidase activity and uric acid levels in acute myocardial infarction rats. ( He, H; Li, X; Liu, X; Liu, Y; Wang, H; Wang, S; Zhang, W, 2017) |
| "Hyperuricemia is significantly associated with hypertension, renal dysfunction, MACE, and independently confers a higher risk of mortality in patients with AMI." | 1.46 | Association Between Hyperuricemia and Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction. ( Mayise, C; Myeni, NN; Ranjith, N; Sartorius, B, 2017) |
| " Chronic use of XO inhibitors, but not uricosuric agent, down-regulated sympathetic innervation probably through a superoxide-dependent pathway and plays a role in the beneficial effect on arrhythmogenic response." | 1.43 | Effects of urate-lowering agents on arrhythmia vulnerability in post-infarcted rat hearts. ( Chang, NC; Lee, TM; Lin, SZ, 2016) |
| "Uric acid (UA) is a strong marker of cardiovascular disease." | 1.40 | The association between serum uric acid level and heart failure and mortality in the early period of ST-elevation acute myocardial infarction. ( Altun, B; Barutçu, A; Bekler, A; Gazi, E; Gazi, S; Güngör, O; Kurt, T; Ozcan, S; Temiz, A; Yener, AU, 2014) |
| "We measured serum FFA levels from type 2 diabetes mellitus (T2DM) and acute myocardial infarction (AMI) patients and assay the correlation between serum FFA levels and related factors." | 1.40 | Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction. ( Han, L; Li, SW; Luo, W; Lv, ZH; Ma, P; Tu, JC; Xiong, H; Zhou, X, 2014) |
| "Uremia was induced by partial nephrectomy in male Wistar rats." | 1.38 | Preconditioning protects the heart in a prolonged uremic condition. ( Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV, 2012) |
| "Uric acid has been shown as a predictor and an independent risk factor for coronary heart disease, but little is known regarding the association of uric acid levels with coronary blood flow in STEMI." | 1.37 | The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. ( Akpek, M; Ardic, I; Dogdu, O; Elcik, D; Ergin, A; Gibson, CM; Gunebakmaz, O; Kalay, N; Kaya, MG; Oguzhan, A; Sahin, O; Uyarel, H; Yarlioglues, M, 2011) |
| "Myocardial infarction affects a large population in the world." | 1.36 | Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study. ( Kumaran, KS; Prince, PS, 2010) |
| "Hyperuricemia has been identified in patients who have congestive heart failure and is a marker of poor prognosis in such patients." | 1.33 | Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). ( Hiraoka, H; Honda, T; Ishihara, M; Kimura, K; Kojima, S; Matsui, K; Miyazaki, S; Ogata, Y; Ogawa, H; Sakamoto, T; Shimoyama, N; Sonoda, M; Tei, C; Tsuchihashi, K; Yamagishi, M, 2005) |
| "Cigarette smoking, hypertension, dyslipidemia, heredity, diabetes mellitus, obesity, beta blockades, and coronary artery bypass surgery are some of the topics discussed." | 1.27 | Preventive cardiology for coronary artery disease. ( Miller, WW, 1985) |
| "Uric acid values were obtained on subjects of the original Framingham cohort at their fourth and 13th biennial examinations." | 1.27 | Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. ( Brand, FN; Castelli, WP; Kannel, WB; McGee, DL; Stokes, J, 1985) |
| "This is a report of 3 patients with cerebral infarct in whom a silent recent myocardial infarction was found." | 1.26 | Coincidence of cerebrovascular accident and silent myocardial infarction. ( Badui, E; Estañol, B; Garcia-Rubi, D, 1982) |
| "Obesity was found in 19 per cent of all patients and serum uric acid levels over 0." | 1.25 | Myocardial infarction in young men. Study of risk factors in nine countries. ( Dolder, MA; Oliver, MF, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 138 (46.15) | 18.7374 |
| 1990's | 20 (6.69) | 18.2507 |
| 2000's | 24 (8.03) | 29.6817 |
| 2010's | 77 (25.75) | 24.3611 |
| 2020's | 40 (13.38) | 2.80 |
| Authors | Studies |
|---|---|
| Tai, CJ | 1 |
| Wu, CC | 2 |
| Lee, KT | 1 |
| Tseng, TG | 1 |
| Wang, HC | 1 |
| Chang, FR | 1 |
| Yang, YH | 1 |
| Chen, Y | 2 |
| Ding, C | 1 |
| Hu, L | 1 |
| Ruan, Y | 1 |
| Zou, K | 1 |
| Dai, C | 1 |
| Liao, Y | 1 |
| Liao, H | 1 |
| Xia, Y | 1 |
| Zhao, Y | 2 |
| Yang, R | 1 |
| Wang, A | 4 |
| Tian, X | 4 |
| Zuo, Y | 4 |
| Chen, S | 7 |
| Mo, D | 2 |
| Zhang, L | 4 |
| Wu, S | 4 |
| Luo, Y | 4 |
| Wang, Y | 1 |
| Huang, Y | 1 |
| Yang, X | 3 |
| Lin, Z | 1 |
| Yan, L | 2 |
| Wang, F | 1 |
| Lin, W | 1 |
| Li, Z | 1 |
| Yang, F | 1 |
| Lu, Y | 1 |
| Wang, K | 1 |
| Hu, T | 1 |
| Cui, H | 2 |
| Şaylık, F | 1 |
| Çınar, T | 1 |
| Akbulut, T | 1 |
| Selçuk, M | 1 |
| Nakahashi, T | 1 |
| Sakata, K | 1 |
| Masuda, J | 1 |
| Kumagai, N | 1 |
| Higuma, T | 1 |
| Ogimoto, A | 1 |
| Tanigawa, T | 1 |
| Hanada, H | 1 |
| Nakamura, M | 1 |
| Takamura, M | 1 |
| Dohi, K | 1 |
| Kajana, V | 1 |
| Massaro, G | 1 |
| Somaschini, A | 1 |
| Cornara, S | 1 |
| Demarchi, A | 1 |
| Nardella, E | 1 |
| Nicoletti, A | 1 |
| Sangiorgi, GM | 1 |
| Mandurino-Mirizzi, A | 1 |
| Li, S | 1 |
| Chen, H | 1 |
| Zhou, L | 1 |
| Liang, S | 1 |
| Li, H | 2 |
| Zeng, G | 1 |
| An, H | 1 |
| Li, W | 1 |
| Fang, D | 1 |
| Sun, M | 1 |
| Zheng, Q | 1 |
| Mackenzie, IS | 1 |
| Hawkey, CJ | 1 |
| Ford, I | 1 |
| Greenlaw, N | 1 |
| Pigazzani, F | 1 |
| Rogers, A | 1 |
| Struthers, AD | 1 |
| Begg, AG | 1 |
| Wei, L | 1 |
| Avery, AJ | 1 |
| Taggar, JS | 1 |
| Walker, A | 1 |
| Duce, SL | 1 |
| Barr, RJ | 1 |
| Dumbleton, JS | 1 |
| Rooke, ED | 1 |
| Townend, JN | 1 |
| Ritchie, LD | 1 |
| MacDonald, TM | 1 |
| Nahar, K | 1 |
| Hasan, MZ | 1 |
| Tuli, JZ | 1 |
| Hoque, MR | 1 |
| Akhter, S | 1 |
| Runa, US | 1 |
| Chen, X | 2 |
| You, J | 1 |
| Zhou, M | 1 |
| Ma, H | 1 |
| Huang, C | 1 |
| McCormick, N | 1 |
| Yokose, C | 1 |
| Wei, J | 1 |
| Lu, N | 1 |
| Wexler, DJ | 1 |
| Aviña-Zubieta, JA | 1 |
| De Vera, MA | 1 |
| Zhang, Y | 3 |
| Choi, HK | 1 |
| Wahid, A | 1 |
| Wen, J | 1 |
| Yang, Q | 1 |
| Zhang, Z | 2 |
| Zhao, X | 1 |
| Tang, X | 1 |
| Roddy, E | 1 |
| Bajpai, R | 1 |
| Forrester, H | 1 |
| Partington, RJ | 1 |
| Mallen, CD | 1 |
| Clarson, LE | 1 |
| Padmanabhan, N | 1 |
| Whittle, R | 1 |
| Muller, S | 1 |
| Bao, F | 1 |
| Yang, C | 1 |
| Zhou, G | 1 |
| Rong, J | 1 |
| Fang, C | 1 |
| Hong, C | 1 |
| Huang, L | 1 |
| Heerkens, L | 1 |
| van Westing, AC | 1 |
| Voortman, T | 1 |
| Kardys, I | 1 |
| Boersma, E | 1 |
| Geleijnse, JM | 1 |
| Wu, X | 1 |
| Xu, Z | 1 |
| Feng, Y | 1 |
| Casiglia, E | 1 |
| Tikhonoff, V | 1 |
| Virdis, A | 1 |
| Masi, S | 1 |
| Barbagallo, CM | 1 |
| Bombelli, M | 1 |
| Bruno, B | 1 |
| Cicero, AFG | 1 |
| Cirillo, M | 1 |
| Cirillo, P | 1 |
| Desideri, G | 1 |
| D'Elia, L | 1 |
| Ferri, C | 1 |
| Galletti, F | 1 |
| Gesualdo, L | 1 |
| Giannattasio, C | 1 |
| Iaccarino, G | 1 |
| Lippa, L | 1 |
| Mallamaci, F | 1 |
| Maloberti, A | 1 |
| Mazza, A | 1 |
| Muiesan, ML | 1 |
| Nazzaro, P | 1 |
| Palatini, P | 1 |
| Parati, G | 1 |
| Pontremoli, R | 1 |
| Quarti-Trevano, F | 1 |
| Rattazzi, M | 1 |
| Rivasi, G | 1 |
| Salvetti, M | 1 |
| Tocci, G | 2 |
| Ungar, A | 1 |
| Verdecchia, P | 1 |
| Viazzi, F | 1 |
| Volpe, M | 1 |
| Grassi, G | 1 |
| Borghi, C | 3 |
| Somuncu, MU | 1 |
| Serbest, NG | 1 |
| Akgül, F | 1 |
| Çakır, MO | 1 |
| Akgün, T | 1 |
| Tatar, FP | 1 |
| Can, M | 1 |
| Tekin, A | 1 |
| Ganapathi, Y | 1 |
| Dharanidharreddy, Y | 1 |
| Kumar, N | 1 |
| Kumar, H | 1 |
| Kumar, V | 1 |
| Nayyer, PS | 1 |
| Lim, SS | 1 |
| Yang, YL | 1 |
| Chen, SC | 1 |
| Wu, CH | 1 |
| Huang, SS | 1 |
| Chan, WL | 1 |
| Lin, SJ | 1 |
| Chen, JW | 1 |
| Chou, CY | 1 |
| Pan, JP | 1 |
| Charng, MJ | 1 |
| Chen, YH | 1 |
| Wu, TC | 1 |
| Lu, TM | 1 |
| Hsu, PF | 1 |
| Huang, PH | 1 |
| Cheng, HM | 1 |
| Huang, CC | 1 |
| Sung, SH | 1 |
| Lin, YJ | 1 |
| Leu, HB | 1 |
| Sessa, C | 1 |
| Granata, A | 1 |
| Gaudio, A | 1 |
| Xourafa, A | 1 |
| Malatino, L | 1 |
| Lentini, P | 1 |
| Fatuzzo, P | 1 |
| Rapisarda, F | 1 |
| Castellino, P | 1 |
| Zanoli, L | 1 |
| He, Y | 2 |
| An, J | 1 |
| Bentivenga, C | 1 |
| Cosentino, ER | 1 |
| Liu, D | 1 |
| Li, YZ | 1 |
| Wu, H | 1 |
| Xu, JJ | 1 |
| Jiang, L | 1 |
| Song, Y | 1 |
| Yao, Y | 1 |
| Jia, SD | 1 |
| Liu, Y | 3 |
| Yuan, DS | 1 |
| Li, TY | 1 |
| Chen, J | 1 |
| Wu, Y | 1 |
| Zhang, J | 1 |
| Chen, JL | 1 |
| Yang, YJ | 1 |
| Gao, RL | 1 |
| Qiao, SB | 1 |
| Xu, B | 2 |
| Yuan, JQ | 1 |
| TianMS, X | 1 |
| ZuoPhD, Y | 1 |
| WangPhD, A | 1 |
| WuMD, S | 1 |
| LuoPhD, Y | 1 |
| Shimizu, W | 1 |
| Kubota, Y | 1 |
| Hoshika, Y | 1 |
| Mozawa, K | 1 |
| Tara, S | 1 |
| Tokita, Y | 1 |
| Yodogawa, K | 1 |
| Iwasaki, YK | 1 |
| Yamamoto, T | 1 |
| Takano, H | 1 |
| Tsukada, Y | 1 |
| Asai, K | 1 |
| Miyamoto, M | 1 |
| Miyauchi, Y | 1 |
| Kodani, E | 1 |
| Ishikawa, M | 1 |
| Maruyama, M | 1 |
| Ogano, M | 1 |
| Tanabe, J | 1 |
| Shi, Y | 1 |
| Zhang, X | 1 |
| Du, J | 1 |
| Zhang, H | 1 |
| Yang, L | 1 |
| Zheng, Z | 1 |
| Shen, S | 1 |
| He, F | 1 |
| Cheng, C | 1 |
| Sheng, J | 1 |
| Demiray, A | 1 |
| Afsar, B | 1 |
| Covic, A | 2 |
| Kuwabara, M | 1 |
| Ferro, CJ | 1 |
| Lanaspa, MA | 1 |
| Johnson, RJ | 2 |
| Kanbay, M | 3 |
| Seki, H | 1 |
| Kaneko, H | 1 |
| Morita, H | 1 |
| Itoh, H | 1 |
| Morita, K | 1 |
| Matsuoka, S | 1 |
| Kiriyama, H | 1 |
| Kamon, T | 1 |
| Fujiu, K | 1 |
| Michihata, N | 1 |
| Jo, T | 1 |
| Takeda, N | 1 |
| Yano, Y | 1 |
| Nakamura, S | 1 |
| Node, K | 1 |
| Yasunaga, H | 1 |
| Komuro, I | 1 |
| Liu, CF | 1 |
| Song, KY | 1 |
| Zhou, WN | 1 |
| Wei, YJ | 1 |
| Itaya, N | 1 |
| Fukami, A | 1 |
| Kakuma, T | 1 |
| Fukumoto, Y | 1 |
| Xu, Q | 1 |
| Zhang, M | 1 |
| Abeysekera, IR | 1 |
| Wang, X | 1 |
| Gwag, HB | 1 |
| Yang, JH | 1 |
| Park, TK | 1 |
| Song, YB | 1 |
| Hahn, JY | 1 |
| Choi, JH | 1 |
| Lee, SH | 2 |
| Gwon, HC | 1 |
| Choi, SH | 1 |
| Hasic, S | 1 |
| Kadic, D | 1 |
| Kiseljakovic, E | 2 |
| Jadric, R | 2 |
| Spahic, E | 1 |
| Larsen, TR | 1 |
| Gerke, O | 1 |
| Diederichsen, ACP | 1 |
| Lambrechtsen, J | 1 |
| Steffensen, FH | 1 |
| Sand, NP | 1 |
| Saaby, L | 1 |
| Antonsen, S | 1 |
| Mickley, H | 1 |
| Abraham, I | 1 |
| Berezin, AE | 1 |
| Li, X | 2 |
| Meng, X | 1 |
| Spiliopoulou, A | 1 |
| Timofeeva, M | 1 |
| Wei, WQ | 1 |
| Gifford, A | 1 |
| Shen, X | 1 |
| Varley, T | 1 |
| McKeigue, P | 1 |
| Tzoulaki, I | 1 |
| Wright, AF | 1 |
| Joshi, P | 1 |
| Denny, JC | 1 |
| Campbell, H | 1 |
| Theodoratou, E | 1 |
| Marković Boras, M | 1 |
| Čaušević, A | 1 |
| Brizić, I | 1 |
| Mikulić, I | 1 |
| Vasilj, M | 1 |
| Jelić Knezović, N | 1 |
| Lv, S | 1 |
| Liu, W | 1 |
| Zhou, Y | 1 |
| Shi, D | 1 |
| Liu, X | 2 |
| Ahmad, MI | 1 |
| Dutta, A | 1 |
| Anees, MA | 1 |
| Soliman, EZ | 1 |
| Song, LL | 1 |
| Zhang, XR | 1 |
| Song, YN | 1 |
| Dai, HZ | 1 |
| Gonçalves, JP | 1 |
| Severo, M | 1 |
| Rangel, I | 1 |
| de Sousa, C | 1 |
| Maciel, MJ | 1 |
| Lopes, C | 1 |
| Lazaros, G | 1 |
| Tsiachris, D | 1 |
| Aznaouridis, K | 1 |
| Vlachopoulos, C | 1 |
| Tsioufis, C | 1 |
| Chrysohoou, C | 1 |
| Patialiakas, A | 1 |
| Masoura, C | 1 |
| Stefanadis, C | 1 |
| Kaya, MG | 3 |
| Yin, Z | 1 |
| Fang, Z | 1 |
| Yang, M | 1 |
| Du, X | 1 |
| Nie, B | 1 |
| Gao, K | 1 |
| Csont, T | 2 |
| Sárközy, M | 2 |
| Szűcs, G | 1 |
| Szűcs, C | 1 |
| Bárkányi, J | 1 |
| Bencsik, P | 2 |
| Gáspár, R | 1 |
| Földesi, I | 1 |
| Csonka, C | 2 |
| Kónya, C | 1 |
| Ferdinandy, P | 2 |
| Balta, S | 1 |
| Demir, M | 1 |
| Demirkol, S | 1 |
| Kucuk, U | 1 |
| Unlu, M | 1 |
| Arslan, Z | 1 |
| Erayman, A | 1 |
| Saritemur, M | 1 |
| Turkeli, M | 1 |
| Kalkan, K | 1 |
| Tanboga, İH | 1 |
| Aksakal, E | 1 |
| Dziuba, J | 1 |
| Alperin, P | 1 |
| Racketa, J | 1 |
| Iloeje, U | 1 |
| Goswami, D | 1 |
| Hardy, E | 1 |
| Perlstein, I | 1 |
| Grossman, HL | 1 |
| Cohen, M | 1 |
| Verdoia, M | 1 |
| Schaffer, A | 1 |
| Barbieri, L | 1 |
| Di Giovine, G | 1 |
| Marino, P | 1 |
| De Luca, G | 1 |
| Liu, Z | 1 |
| Zhang, C | 1 |
| Gazi, E | 1 |
| Temiz, A | 1 |
| Altun, B | 1 |
| Barutçu, A | 1 |
| Bekler, A | 1 |
| Güngör, O | 1 |
| Yener, AU | 1 |
| Kurt, T | 1 |
| Ozcan, S | 1 |
| Gazi, S | 1 |
| Eren, M | 2 |
| Lv, ZH | 1 |
| Ma, P | 1 |
| Luo, W | 1 |
| Xiong, H | 1 |
| Han, L | 1 |
| Li, SW | 1 |
| Zhou, X | 1 |
| Tu, JC | 1 |
| Acet, H | 1 |
| Ertaş, F | 1 |
| Akıl, MA | 1 |
| Özyurtlu, F | 1 |
| Yıldız, A | 1 |
| Polat, N | 1 |
| Bilik, MZ | 1 |
| Aydın, M | 1 |
| Oylumlu, M | 1 |
| Kaya, H | 1 |
| Yüksel, M | 1 |
| Akyüz, A | 1 |
| Ayçiçek, H | 1 |
| Alan, S | 1 |
| Toprak, N | 1 |
| de Abajo, FJ | 1 |
| Gil, MJ | 1 |
| Rodríguez, A | 1 |
| García-Poza, P | 1 |
| Álvarez, A | 1 |
| Bryant, V | 1 |
| García-Rodríguez, LA | 1 |
| Lazzeri, C | 6 |
| Valente, S | 6 |
| Chiostri, M | 5 |
| Spini, V | 1 |
| Angelotti, P | 1 |
| Gensini, GF | 6 |
| Cicero, AF | 1 |
| Rosticci, M | 1 |
| Bacchelli, S | 1 |
| Urso, R | 1 |
| D'Addato, S | 1 |
| Zhang, N | 1 |
| Yang, Y | 1 |
| Xu, Y | 1 |
| Li, G | 1 |
| Liu, T | 1 |
| Baumann, S | 1 |
| Huseynov, A | 1 |
| Koepp, J | 1 |
| Jabbour, C | 1 |
| Behnes, M | 1 |
| Becher, T | 1 |
| Renker, M | 1 |
| Lang, S | 1 |
| Borggrefe, M | 1 |
| Lehmann, R | 1 |
| Akin, I | 1 |
| Fu, Z | 1 |
| Qian, G | 1 |
| Xue, H | 1 |
| Guo, J | 1 |
| Chen, L | 1 |
| Shen, M | 1 |
| Dong, W | 1 |
| von Lueder, TG | 1 |
| Girerd, N | 1 |
| Atar, D | 1 |
| Agewall, S | 1 |
| Lamiral, Z | 1 |
| Pitt, B | 1 |
| Dickstein, K | 1 |
| Zannad, F | 1 |
| Rossignol, P | 1 |
| Karataş, MB | 1 |
| Çanga, Y | 1 |
| İpek, G | 1 |
| Özcan, KS | 1 |
| Güngör, B | 1 |
| Durmuş, G | 1 |
| Onuk, T | 1 |
| Öz, A | 1 |
| Şimşek, B | 2 |
| Bolca, O | 1 |
| Eyuboglu, M | 1 |
| Shacham, Y | 1 |
| Steinvil, A | 1 |
| Arbel, Y | 1 |
| Vassalle, C | 1 |
| Chatzianagnostou, K | 1 |
| Vannucci, A | 1 |
| Guiducci, L | 1 |
| Battaglia, D | 1 |
| Maffei, S | 1 |
| Arvia, C | 1 |
| Landi, P | 1 |
| Carpeggiani, C | 1 |
| Lee, TM | 2 |
| Lin, SZ | 1 |
| Chang, NC | 1 |
| Wang, H | 1 |
| Zhang, W | 1 |
| Wang, S | 1 |
| He, H | 1 |
| Liu, CW | 1 |
| Shi, JH | 1 |
| Xing, AJ | 1 |
| Wang, YZ | 1 |
| Ji, CP | 1 |
| Zhu, CR | 1 |
| Wei, XM | 1 |
| Wu, SL | 1 |
| Ma, QQ | 1 |
| Yang, XJ | 1 |
| Yang, NQ | 1 |
| Liu, L | 1 |
| Li, XD | 1 |
| Zhu, K | 1 |
| Fu, Q | 1 |
| Wei, P | 1 |
| Ranjith, N | 1 |
| Myeni, NN | 1 |
| Sartorius, B | 1 |
| Mayise, C | 1 |
| Tsai, IT | 1 |
| Wang, CP | 1 |
| Lu, YC | 1 |
| Hung, WC | 1 |
| Lu, LF | 1 |
| Chung, FM | 1 |
| Hsu, CC | 1 |
| Lee, YJ | 1 |
| Yu, TH | 1 |
| Essex, MN | 1 |
| Hopps, M | 1 |
| Bienen, EJ | 1 |
| Udall, M | 1 |
| Mardekian, J | 1 |
| Makinson, GT | 1 |
| Mehrpooya, M | 1 |
| Larti, F | 1 |
| Nozari, Y | 2 |
| Sattarzadeh-Badkoobeh, R | 1 |
| Zand Parsa, AF | 1 |
| Zebardast, J | 1 |
| Tavoosi, A | 1 |
| Shahbazi, F | 1 |
| Tatli, E | 1 |
| Aktoz, M | 1 |
| Buyuklu, M | 1 |
| Altun, A | 1 |
| Sori, A | 1 |
| Bernardo, P | 1 |
| Padmanabhan, M | 1 |
| Rajadurai, M | 2 |
| Prince, PS | 4 |
| Priscilla, DH | 1 |
| Celik, T | 1 |
| Iyisoy, A | 1 |
| Nadkar, MY | 1 |
| Jain, VI | 1 |
| Nivethetha, M | 1 |
| Jayasri, J | 1 |
| Brindha, P | 1 |
| Holme, I | 2 |
| Aastveit, AH | 2 |
| Hammar, N | 2 |
| Jungner, I | 2 |
| Walldius, G | 2 |
| Brodov, Y | 2 |
| Chouraqui, P | 2 |
| Goldenberg, I | 1 |
| Boyko, V | 2 |
| Mandelzweig, L | 1 |
| Behar, S | 2 |
| Car, S | 2 |
| Trkulja, V | 2 |
| Kumaran, KS | 1 |
| Strutyns'kyĭ, RB | 1 |
| Kotsiuruba, AV | 1 |
| Neshcheret, OP | 1 |
| Shysh, AM | 1 |
| Rovenets', RA | 1 |
| Moĭbenko, OO | 1 |
| Spoon, DB | 1 |
| Lerman, A | 1 |
| Rule, AD | 1 |
| Prasad, A | 1 |
| Lennon, RJ | 1 |
| Holmes, DR | 1 |
| Rihal, CS | 1 |
| Tarquini, R | 1 |
| Picariello, C | 2 |
| Park, SH | 2 |
| Shin, WY | 1 |
| Lee, EY | 1 |
| Gil, HW | 1 |
| Lee, SW | 1 |
| Lee, SJ | 1 |
| Jin, DK | 1 |
| Hong, SY | 1 |
| Dorsch, MP | 1 |
| Gillespie, BW | 1 |
| Erickson, SR | 1 |
| Bleske, BE | 1 |
| Weder, AB | 1 |
| Basar, N | 1 |
| Sen, N | 1 |
| Ozcan, F | 1 |
| Erden, G | 1 |
| Kanat, S | 1 |
| Sokmen, E | 1 |
| Isleyen, A | 1 |
| Yuzgecer, H | 1 |
| Ozlu, MF | 1 |
| Yildirimkaya, M | 1 |
| Maden, O | 1 |
| Bae, MH | 1 |
| Lee, JH | 1 |
| Yang, DH | 1 |
| Park, HS | 1 |
| Cho, Y | 1 |
| Jun, JE | 1 |
| Chae, SC | 1 |
| Silver, SA | 1 |
| Huang, M | 1 |
| Nash, MM | 1 |
| Prasad, GV | 1 |
| Chen, CC | 1 |
| Hsu, YJ | 1 |
| Akpek, M | 2 |
| Uyarel, H | 2 |
| Yarlioglues, M | 1 |
| Kalay, N | 2 |
| Gunebakmaz, O | 1 |
| Dogdu, O | 1 |
| Ardic, I | 1 |
| Elcik, D | 2 |
| Sahin, O | 2 |
| Oguzhan, A | 2 |
| Ergin, A | 1 |
| Gibson, CM | 2 |
| Valjevac, A | 1 |
| Dzubur, A | 1 |
| Nakas-Icindic, E | 1 |
| Hadzovic-Dzuvo, A | 1 |
| Lepara, O | 1 |
| Nayak, BS | 1 |
| Maharaj, N | 1 |
| Maharaj, SS | 1 |
| Evernden, K | 1 |
| Fane, U | 1 |
| Fatt, LA | 1 |
| Maharaj, D | 1 |
| Maharaj, S | 1 |
| Maharaj, V | 1 |
| Maloney, V | 1 |
| Geraiely, B | 1 |
| Ergelen, M | 1 |
| Ayhan, E | 1 |
| Isik, T | 1 |
| Cicek, G | 1 |
| Cosgun, SM | 1 |
| Zhang, B | 1 |
| Gao, C | 1 |
| Hou, Q | 1 |
| Yin, J | 1 |
| Xie, L | 1 |
| Pu, S | 1 |
| Yi, Y | 1 |
| Gao, Q | 1 |
| Krishnan, E | 1 |
| Pandya, BJ | 1 |
| Lingala, B | 1 |
| Hariri, A | 1 |
| Dabbous, O | 1 |
| Levantesi, G | 1 |
| Marfisi, RM | 1 |
| Franzosi, MG | 1 |
| Maggioni, AP | 1 |
| Nicolosi, GL | 1 |
| Schweiger, C | 1 |
| Silletta, MG | 1 |
| Tavazzi, L | 1 |
| Tognoni, G | 1 |
| Marchioli, R | 1 |
| Crittenden, DB | 1 |
| Lehmann, RA | 1 |
| Schneck, L | 1 |
| Keenan, RT | 1 |
| Shah, B | 1 |
| Greenberg, JD | 1 |
| Cronstein, BN | 1 |
| Sedlis, SP | 1 |
| Pillinger, MH | 1 |
| Kannan, MM | 1 |
| Quine, SD | 1 |
| Sangeetha, T | 1 |
| Kocsis, GF | 1 |
| Pipicz, M | 1 |
| Varga, ZV | 1 |
| Pálóczi, J | 1 |
| Elbasan, Z | 1 |
| Şahin, DY | 1 |
| Gür, M | 1 |
| Kuloğlu, O | 1 |
| Kivrak, A | 1 |
| Içen, YK | 1 |
| Türkoglu, C | 1 |
| Yildirim, A | 1 |
| Özdogru, I | 1 |
| Çayli, M | 1 |
| Zhou, C | 1 |
| Wu, J | 1 |
| Fang, S | 1 |
| Wildi, K | 1 |
| Haaf, P | 1 |
| Reichlin, T | 1 |
| Acemoglu, R | 1 |
| Schneider, J | 1 |
| Balmelli, C | 1 |
| Drexler, B | 1 |
| Twerenbold, R | 1 |
| Mosimann, T | 1 |
| Reiter, M | 1 |
| Mueller, M | 1 |
| Ernst, S | 1 |
| Ballarino, P | 1 |
| Zellweger, C | 1 |
| Moehring, B | 1 |
| Vilaplana, C | 1 |
| Freidank, H | 1 |
| Mueller, C | 1 |
| Wang, JW | 1 |
| Chen, YD | 1 |
| Wang, CH | 1 |
| Zhu, XL | 1 |
| Reyes, AJ | 1 |
| Leary, WP | 1 |
| KOHN, PM | 1 |
| PROZAN, GB | 1 |
| LOVERING, EF | 1 |
| LONGOBARDI, A | 1 |
| LAL, HB | 1 |
| LAL, H | 1 |
| MCKECHNIE, JK | 1 |
| DAVIDSON, FJ | 1 |
| OLIVER, MF | 2 |
| Assanelli, D | 1 |
| Bonanome, A | 1 |
| Pezzini, A | 1 |
| Albertini, F | 1 |
| Maccalli, P | 2 |
| Grassi, M | 1 |
| Archetti, S | 1 |
| Negrini, R | 2 |
| Visioli, F | 1 |
| STORTI, R | 1 |
| von Haehling, S | 1 |
| Hayden, MR | 1 |
| Tyagi, SC | 1 |
| Kojima, S | 1 |
| Sakamoto, T | 1 |
| Ishihara, M | 1 |
| Kimura, K | 1 |
| Miyazaki, S | 1 |
| Yamagishi, M | 1 |
| Tei, C | 1 |
| Hiraoka, H | 1 |
| Sonoda, M | 1 |
| Tsuchihashi, K | 1 |
| Shimoyama, N | 1 |
| Honda, T | 1 |
| Ogata, Y | 1 |
| Matsui, K | 1 |
| Ogawa, H | 1 |
| Simon, JA | 1 |
| Bos, MJ | 1 |
| Koudstaal, PJ | 1 |
| Hofman, A | 1 |
| Witteman, JC | 1 |
| Breteler, MM | 1 |
| Tuck, ML | 1 |
| Corry, DB | 1 |
| Petersen, TS | 1 |
| Madsen, TV | 1 |
| Jespersen, JB | 1 |
| Larsen, A | 1 |
| Schmidt, EB | 1 |
| Christensen, JH | 1 |
| Stark, K | 1 |
| Reinhard, W | 1 |
| Neureuther, K | 1 |
| Wiedmann, S | 1 |
| Sedlacek, K | 1 |
| Baessler, A | 1 |
| Fischer, M | 1 |
| Weber, S | 1 |
| Kaess, B | 1 |
| Erdmann, J | 1 |
| Schunkert, H | 1 |
| Hengstenberg, C | 1 |
| Kopp, H | 1 |
| London, M | 1 |
| Hums, M | 1 |
| Benedek, TG | 2 |
| Oberman, A | 1 |
| Ostrander, LD | 1 |
| Epstein, FH | 1 |
| Bozyk, Z | 1 |
| Wekka, Z | 1 |
| Kannel, WB | 2 |
| Castelli, WP | 2 |
| McNamara, PM | 1 |
| Walter, E | 1 |
| Staiger, C | 1 |
| Elmfeldt, D | 1 |
| Berglund, G | 1 |
| Wedel, H | 1 |
| Wilhelmsen, L | 1 |
| Badui, E | 1 |
| Estañol, B | 1 |
| Garcia-Rubi, D | 1 |
| Ambrosch, P | 1 |
| Neuberger, M | 1 |
| Bayliss, R | 1 |
| Clarke, C | 1 |
| Whitehead, TP | 1 |
| Whitfield, AG | 1 |
| Cortellaro, M | 1 |
| Boschetti, C | 1 |
| Antoniazzi, V | 1 |
| Polli, EE | 1 |
| de Gaetano, G | 1 |
| De Blasi, A | 1 |
| Gerna, M | 1 |
| Pezzi, L | 1 |
| Garattini, S | 1 |
| Angster, H | 1 |
| Glonner, R | 1 |
| Halhuber, M | 1 |
| Válek, J | 2 |
| Hammer, J | 2 |
| Vondra, K | 1 |
| Grafnetter, D | 2 |
| Slabochová, Z | 2 |
| Kohout, M | 1 |
| Stolz, I | 2 |
| Perry, HM | 1 |
| Kaucká, J | 1 |
| Wilcox, RG | 1 |
| Richardson, D | 1 |
| Hampton, JR | 1 |
| Mitchell, JR | 1 |
| Banks, DC | 1 |
| Rafnsson, V | 1 |
| Bengtsson, C | 1 |
| Chapelle, JP | 1 |
| Albert, A | 1 |
| Boland, J | 1 |
| Smeets, JP | 1 |
| Heusghem, C | 1 |
| Kulbertus, HE | 1 |
| Müller, M | 1 |
| Kuzmits, R | 1 |
| Frassine, I | 1 |
| Lorant, P | 1 |
| Noppa, H | 1 |
| Barriales Alvarez, V | 1 |
| Rodríguez Blanco, VM | 1 |
| Barriales Villa, R | 1 |
| Möller Bustinza, I | 1 |
| Batalla Celorio, A | 1 |
| Castellanos Martínez, E | 1 |
| Moris de la Tassa, C | 1 |
| Mayordomo López, J | 1 |
| Kock, R | 1 |
| Delvoux, B | 1 |
| Sigmund, M | 1 |
| Greiling, H | 1 |
| Rogner, J | 1 |
| Hardinghaus, W | 1 |
| Bartram, M | 1 |
| Wirth, A | 1 |
| Giardina, B | 1 |
| Penco, M | 1 |
| Lazzarino, G | 1 |
| Romano, S | 1 |
| Tavazzi, B | 1 |
| Fedele, F | 1 |
| Di Pierro, D | 1 |
| Dagianti, A | 1 |
| Pucheu, S | 1 |
| Coudray, C | 1 |
| Vanzetto, G | 1 |
| Favier, A | 1 |
| Machecourt, J | 1 |
| de Leiris, J | 1 |
| Brestrich, M | 1 |
| Claus, J | 1 |
| Blümchen, G | 1 |
| Miller, NJ | 1 |
| Johnston, JD | 1 |
| Collis, CS | 1 |
| Rice-Evans, C | 1 |
| Ariza, CR | 1 |
| Frati, AC | 1 |
| Gómez, G | 1 |
| Almazán, A | 1 |
| Wannamethee, SG | 1 |
| Shaper, AG | 1 |
| Whincup, PH | 1 |
| Sattar, N | 1 |
| Blacklock, C | 1 |
| Mei, DA | 1 |
| Nithipatikom, K | 1 |
| Lasley, RD | 1 |
| Gross, GJ | 1 |
| Torun, M | 1 |
| Yardim, S | 1 |
| Burgaz, S | 1 |
| Liese, AD | 1 |
| Hense, HW | 1 |
| Löwel, H | 1 |
| Döring, A | 1 |
| Tietze, M | 1 |
| Keil, U | 1 |
| Longo-Mbenza, B | 1 |
| Luila, EL | 1 |
| Mbete, P | 1 |
| Vita, EK | 1 |
| Domański, L | 2 |
| Tereshchenko, SN | 1 |
| Levchuk, NN | 1 |
| Drozdov, VN | 1 |
| Moiseev, VS | 1 |
| Pietrzak-Nowacka, M | 1 |
| Szmatłoch, E | 1 |
| Wójcicki, J | 1 |
| Droździk, M | 1 |
| Weidmann, P | 1 |
| Fuss, O | 1 |
| Anisimov, VE | 1 |
| Zheltukhina, VV | 1 |
| Semavin, IE | 1 |
| Krupar, V | 1 |
| Manton, KG | 1 |
| Woodbury, MA | 1 |
| Stallard, E | 1 |
| Marek, H | 1 |
| Kuklinski, B | 1 |
| Kellner, K | 1 |
| Göbel, S | 1 |
| Grossmann, KD | 1 |
| Singh, V | 1 |
| Goyal, RK | 1 |
| Oberwittler, W | 2 |
| Schulte, H | 1 |
| Wexler, BC | 1 |
| Greenberg, BP | 1 |
| Beloev, I | 1 |
| Orbetsov, M | 1 |
| Dzhonov, A | 1 |
| Atanasov, I | 1 |
| Blanc, JJ | 2 |
| Boschat, J | 2 |
| Morin, JF | 1 |
| Granatelli, D | 2 |
| Floch, H | 1 |
| Penther, P | 2 |
| Zdichynec, B | 2 |
| Jacobs, D | 3 |
| Ljunghall, S | 1 |
| Hedstrand, H | 1 |
| Ballantyne, D | 1 |
| Strevens, EA | 1 |
| Lawrie, TD | 1 |
| Beaumont, V | 1 |
| Jacotot, B | 1 |
| Beaumont, JL | 1 |
| Wiener, K | 1 |
| Germa, D | 1 |
| Klemens, UH | 1 |
| von Löwis of Menar, P | 1 |
| Dosman, JA | 2 |
| Crawhall, JC | 2 |
| Klassen, GA | 2 |
| Dolder, MA | 1 |
| Ghosh, P | 1 |
| Cochrane, AM | 1 |
| Gordon, PW | 1 |
| Radcliffe, AG | 1 |
| Hartl, O | 1 |
| Clodi, PH | 1 |
| Rahe, RH | 1 |
| De Scheerder, IK | 1 |
| van de Kraay, AM | 1 |
| Lamers, JM | 1 |
| Koster, JF | 1 |
| de Jong, JW | 1 |
| Serruys, PW | 1 |
| Agamah, ES | 1 |
| Srinivasan, SR | 1 |
| Webber, LS | 1 |
| Berenson, GS | 1 |
| Sewdarsen, M | 1 |
| Vythilingum, S | 1 |
| Jialal, I | 1 |
| Kamdar, MC | 1 |
| Brugger, P | 1 |
| Schwartzkopff, W | 1 |
| Schleicher, J | 1 |
| Pottins, I | 1 |
| Yu, SB | 1 |
| Han, CZ | 1 |
| Du, DY | 1 |
| Nisa, Z | 1 |
| Majid, T | 1 |
| Smith, P | 1 |
| Arnesen, H | 1 |
| Miller, WW | 1 |
| Brand, FN | 1 |
| McGee, DL | 1 |
| Stokes, J | 1 |
| Arsent'ev, FV | 1 |
| Namestnikov, VV | 1 |
| Shustov, SS | 1 |
| Barkov, VA | 1 |
| Malaia, LT | 1 |
| Reus, LP | 1 |
| Bondarenko, MI | 1 |
| Negri, M | 1 |
| Riva, M | 1 |
| Broccolino, M | 1 |
| Volpi, M | 1 |
| Galbiati, N | 1 |
| Thiele, R | 1 |
| Kirchner, C | 1 |
| Dietel, M | 1 |
| Scheibe, J | 1 |
| Prabhant, C | 1 |
| Tantrarongroj, S | 1 |
| Manochiopinij, S | 1 |
| Sirisali, K | 1 |
| Lowe, GD | 1 |
| Machado, SG | 1 |
| Krol, WF | 1 |
| Barton, BA | 1 |
| Forbes, CD | 1 |
| De Moor, P | 1 |
| Bouillon, R | 1 |
| Van Mieghem, W | 1 |
| Jouve, A | 1 |
| Sommer, A | 1 |
| Avierinos, C | 1 |
| Fondarai, J | 1 |
| Berman, BH | 1 |
| Leon, DF | 1 |
| Hazzard, WR | 2 |
| Goldstein, JL | 2 |
| Schrott, MG | 1 |
| Motulsky, AG | 2 |
| Bierman, EL | 2 |
| Bertrand, E | 1 |
| Baudin, L | 1 |
| Chauvet, J | 1 |
| Assamoi, MO | 1 |
| Beda, B | 1 |
| Renambot, J | 1 |
| Thomas, JY | 1 |
| Le Bras, M | 1 |
| Adsett, CA | 1 |
| Bruhn, JG | 1 |
| Mikus, F | 2 |
| Grígel, M | 1 |
| Jakubovský, J | 1 |
| Mikusová, A | 1 |
| Heyden, S | 5 |
| Srivastava, BN | 1 |
| Om, H | 1 |
| Deshmankar, BS | 1 |
| Gupta, RK | 1 |
| Hollander, IJ | 1 |
| Ghani, MF | 1 |
| Parker, BM | 1 |
| Smith, JR | 1 |
| Escher, M | 1 |
| O'Sullivan, WJ | 1 |
| Fox, IH | 1 |
| Veglia, L | 1 |
| Shvatsabaia, LV | 1 |
| Lavicka, J | 1 |
| Klör, HU | 1 |
| Märtens, HR | 1 |
| van Eimeren, W | 1 |
| Härich, B | 1 |
| Ditschuneit, H | 1 |
| Schettler, G | 1 |
| Aronow, WS | 1 |
| Uyeyama, RR | 1 |
| Cassidy, J | 1 |
| Schrott, HG | 1 |
| Paasikivi, J | 1 |
| Seftel, HC | 2 |
| Spitz, IM | 1 |
| Bersohn, I | 1 |
| Goldin, AR | 1 |
| Joffe, BI | 1 |
| Rubenstein, AH | 1 |
| Metzger, BE | 1 |
| Tiso, B | 1 |
| Herrlein, A | 1 |
| McEwin, R | 1 |
| McEwin, K | 1 |
| Loudon, B | 1 |
| Fletcher, GF | 1 |
| Cantwell, JD | 1 |
| Bjernulf, A | 1 |
| Boberg, J | 1 |
| Simon, J | 1 |
| Sova, J | 1 |
| Svojgrová, M | 1 |
| Voleníková, L | 1 |
| Rochová, J | 1 |
| Briggs, MH | 1 |
| Villiger, U | 3 |
| Mertz, P | 1 |
| Felt, V | 1 |
| Sunder, JH | 1 |
| Liebscher, K | 1 |
| Rückert, KH | 1 |
| Chowanetz, W | 1 |
| Cullen, KJ | 1 |
| Theorell, T | 1 |
| Ledwich, JR | 1 |
| Smith, RB | 1 |
| Kiddle, GB | 1 |
| Prior, IA | 1 |
| Liljefors, I | 1 |
| Barbeau, A | 1 |
| Mars, H | 1 |
| Gillo-Joffroy, L | 1 |
| Levi, J | 1 |
| Bicher, HI | 1 |
| Rosenfeld, J | 1 |
| Susić, D | 2 |
| Bäumer, A | 2 |
| Schultz, D | 1 |
| Kew, MC | 1 |
| Gertler, MM | 1 |
| Leetma, HE | 1 |
| Saluste, E | 1 |
| Welsh, JJ | 1 |
| Rusk, HA | 1 |
| Covalt, DA | 1 |
| Rosenberger, J | 1 |
| Chirillo, R | 1 |
| Toschi, P | 1 |
| Gupta, BK | 1 |
| Chandra, J | 1 |
| Singh, KN | 1 |
| Govil, MK | 1 |
| Agrawal, SG | 1 |
| Tägert, J | 1 |
| Thiele, P | 1 |
| Heidelmann, G | 1 |
| Gärtner, A | 1 |
| Schneider, V | 1 |
| Tellkamp, F | 1 |
| Askanas, Z | 1 |
| Liszewska, D | 1 |
| Tylka, J | 1 |
| Van Goor, W | 1 |
| Kooiker, CJ | 1 |
| Mees, EJ | 1 |
| Puri, AS | 3 |
| Prakash, C | 1 |
| Mathur, OC | 3 |
| Sharma, R | 3 |
| Tremblay, GM | 1 |
| Charland, R | 1 |
| Roy, P | 1 |
| Primeau, R | 1 |
| Ciświcka-Sznajderman, M | 2 |
| Ignatowska, H | 2 |
| Sznajderman, M | 2 |
| Rizzon, P | 2 |
| Human, GP | 1 |
| Snyman, HW | 1 |
| Parkash, C | 1 |
| Bacca, F | 1 |
| Brindicci, G | 1 |
| Glass, HI | 1 |
| Scott, JT | 1 |
| Gilles, DC | 1 |
| Arnot, RN | 1 |
| Holloway, VP | 1 |
| Ben Hameid, SS | 1 |
| Bector, NP | 1 |
| Hood, B | 1 |
| Tibblin, G | 1 |
| Welin, G | 1 |
| Orndahl, G | 1 |
| Korsan-Bengtsen, K | 1 |
| Khosla, HL | 1 |
| Caroli, RK | 1 |
| Gupta, S | 1 |
| Bahl, AN | 1 |
| Heyden-Stucky, S | 1 |
| O'Brien, JR | 1 |
| Heywood, JB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Allopurinol in the Treatment of Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Treated by Either PCI or CABG: Pilot Study[NCT03700645] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-12-01 | Not yet recruiting | ||
| Serum Uric Acid Levels and Initial Presentation of Cardiovascular Diseases: a CALIBER Study[NCT03425305] | 180,000 participants (Actual) | Observational | 1998-01-31 | Active, not recruiting | |||
| Comparisons Of Inflammatory Biomarkers And Cardiovascular Risk Scores Before And After Conversion To Full Dose Myfortic® Using Two Hour Neoral® Monitoring.[NCT02058875] | Phase 4 | 0 participants (Actual) | Interventional | 2014-02-28 | Withdrawn (stopped due to The study funder retracted their grant funding offer before contract signed.) | ||
| Effectiveness of Colchicine Among Patients With COVID-19 Infection[NCT04867226] | Phase 2 | 100 participants (Actual) | Interventional | 2021-05-08 | Completed | ||
| [NCT00000482] | Phase 3 | 0 participants | Interventional | 1965-04-30 | Completed | ||
| The Bogalusa Heart Study[NCT00005129] | 11,737 participants (Actual) | Observational | 1972-06-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for uric acid and Myocardial Infarction
| Article | Year |
|---|---|
Serum uric acid in patients with ST-segment elevation myocardial infarction: An innocent bystander or leading actor?
Topics: Humans; Myocardial Infarction; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarctio | 2022 |
Association of serum uric acid with prognosis in patients with myocardial infarction: an update systematic review and meta-analysis.
Topics: Female; Hospitalization; Humans; Length of Stay; Male; Myocardial Infarction; Prognosis; Uric Acid | 2023 |
[Vascular dysfunction in Cardiorenal Syndrome type 4].
Topics: Aorta; Arginine; Autonomic Nervous System Diseases; Bone Diseases, Metabolic; Cardio-Renal Syndrome; | 2020 |
The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative Review.
Topics: Coronary Artery Disease; Humans; Myocardial Infarction; Risk Factors; Uric Acid | 2022 |
High serum uric acid levels may increase mortality and major adverse cardiovascular events in patients with acute myocardial infarction.
Topics: Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Uric Acid | 2017 |
Uric acid as a predictor of in-hospital mortality in acute myocardial infarction: a meta-analysis.
Topics: Biomarkers; Hospital Mortality; Humans; Myocardial Infarction; Prevalence; Prognosis; Reproducibilit | 2014 |
Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity.
Topics: Acute Kidney Injury; Anemia; Biomarkers; Blood Glucose; Contrast Media; Hemodynamics; Hemoglobins; H | 2016 |
On-admission serum uric acid predicts outcomes after acute myocardial infarction: systematic review and meta-analysis of prognostic studies.
Topics: Biomarkers; Follow-Up Studies; Global Health; Humans; Length of Stay; Myocardial Infarction; Patient | 2012 |
Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review.
Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Antioxidants; Cholesterol, HDL; Coronary A | 2005 |
[Drug therapy in hypertension 1977. Empirical and rational viewpoints].
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Age Factors; Aged; Blood Volume; Diuretics; Drug The | 1978 |
[Coffee-drinking from the medical point of view].
Topics: Adult; Blood Pressure; Caffeine; Coffee; Diabetes Mellitus; Feeding Behavior; Female; Gout; Health S | 1973 |
Orotic acid.
Topics: Allopurinol; Anemia, Pernicious; Animals; Azauridine; Carboxy-Lyases; Fatty Liver; Female; Humans; I | 1973 |
Purine ribonucleotide catabolism: clinical and biochemical significance. Review.
Topics: Adenosine Triphosphate; Allopurinol; Animals; Carbohydrate Metabolism, Inborn Errors; Fructose; Huma | 1974 |
[New Results of epidemiologic research in ischemic heart disease. 1. Biochemical findings--dietic studies--studies on the effect of nicotine].
Topics: Cholesterol; Coronary Disease; Diet Therapy; Female; Humans; Male; Middle Aged; Myocardial Infarctio | 1966 |
[The kidney in gout and gout of the kidney].
Topics: Arteriosclerosis Obliterans; Carbohydrate Metabolism; Cerebrovascular Disorders; Diabetes Complicati | 1968 |
20 trials available for uric acid and Myocardial Infarction
| Article | Year |
|---|---|
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Topics: Aged; Allopurinol; Coronary Artery Disease; Female; Gout; Humans; Male; Myocardial Infarction; Myoca | 2022 |
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
Topics: 3-Iodobenzylguanidine; Aged; Benzhydryl Compounds; Blood Pressure; Body Weight; Death, Sudden, Cardi | 2020 |
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
Topics: Aged; Biomarkers; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infa | 2015 |
Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
Topics: Aged; Bezafibrate; Blood Glucose; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; | 2010 |
Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Follow-Up Studies; Human | 2013 |
Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients.
Topics: Adult; Antioxidants; Diagnostic Techniques and Procedures; Dietary Supplements; Drug Administration | 2004 |
Sulphinpyrazone, aspirin, and uric acid.
Topics: Aspirin; Death, Sudden; Humans; Myocardial Infarction; Sulfinpyrazone; Uric Acid | 1980 |
Incidence and importance of metabolic side-effects during antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Bendroflumethiazide; Blood Glucose; Cholesterol; Clinical Trials as Top | 1983 |
Blood pressure in survivors of myocardial infarction. The Coronary Drug Project Research Group.
Topics: Adult; Age Factors; Blood Glucose; Blood Pressure; Body Weight; Electrocardiography; Heart Rate; Hum | 1984 |
A pharmacokinetic and platelet function study of the combined administration of metoprolol and sulfinpyrazone to healthy volunteers.
Topics: Adult; Blood Platelets; Drug Therapy, Combination; Humans; Male; Metoprolol; Middle Aged; Myocardial | 1984 |
Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Creatinine; Double-Blind Method; Female; Humans; Mal | 1980 |
The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Topics: Aspirin; Blood Pressure; Blood Urea Nitrogen; Cerebrovascular Disorders; Clinical Trials as Topic; C | 1980 |
[Lactovegetarian diet: effect on changes in body weight, lipid status, fibrinogen and lipoprotein (a) in cardiovascular patients during inpatient rehabilitation treatment].
Topics: Adult; Aged; Body Weight; Cardiac Rehabilitation; Cardiovascular Diseases; Cholesterol; Cholesterol, | 1996 |
Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans?
Topics: Black People; Coronary Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middl | 1999 |
[Cortisol levels in blood of persons with acute myocardial ischemia and myocardial infarction].
Topics: Adult; Aged; Ascorbic Acid; Female; Free Radicals; Humans; Hydrocortisone; Leukocyte Count; Male; Ma | 1999 |
Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Topics: Aged; Blood Platelets; Clinical Trials as Topic; Death, Sudden; Depression, Chemical; Double-Blind M | 1978 |
Serum uric acid: its association with other risk factors and with mortality in coronary heart disease.
Topics: Adult; Aged; Diuretics; Follow-Up Studies; Gout; Humans; Male; Middle Aged; Myocardial Infarction; P | 1976 |
Warfarin and uric acid after myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pro | 1986 |
The coronary drug project. Design, methods, and baseline results.
Topics: Adult; Alkaline Phosphatase; Anticholesteremic Agents; Bilirubin; Blood Glucose; Blood Pressure; Blo | 1973 |
[Coronary diseases, hyperuricemia and benziodarone. Personal considerations].
Topics: Acute Disease; Arteriosclerosis; Benzofurans; Cholesterol; Clinical Trials as Topic; Female; Humans; | 1974 |
264 other studies available for uric acid and Myocardial Infarction
| Article | Year |
|---|---|
The Impact of Urate-Lowering Therapy in Post-Myocardial Infarction Patients: Insights From a Population-Based, Propensity Score-Matched Analysis.
Topics: Aged; Anti-Inflammatory Agents; Coronary Artery Bypass; Female; Humans; Longitudinal Studies; Male; | 2022 |
Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction.
Topics: Aged; Biomarkers; China; Cholesterol, LDL; Dyslipidemias; Female; Hospitalization; Humans; Hyperuric | 2021 |
Effect of changes in serum uric acid on the risk of stroke and its subtypes.
Topics: Adult; Humans; Hyperuricemia; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; U | 2022 |
Impact of serum uric acid on subclinical myocardial injury in general population.
Topics: Adult; Female; Humans; Hyperuricemia; Male; Myocardial Infarction; Nutrition Surveys; Risk Factors; | 2022 |
Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: A Mendelian randomization study.
Topics: Coronary Disease; Female; Genome-Wide Association Study; Humans; Male; Mendelian Randomization Analy | 2022 |
Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Albumins; Contrast Media; Creatinine; Humans; Kidney Diseases; Myocardial Infar | 2023 |
Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Female; Hospital Mortality; Humans; Hyperuricemia; Male; Myocardial Infarction; Percutaneous Coronar | 2022 |
The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention.
Topics: Aftercare; Albumins; Angina, Unstable; Humans; Myocardial Infarction; Patient Discharge; Percutaneou | 2022 |
High serum uric acid trajectories are associated with risk of myocardial infarction and all-cause mortality in general Chinese population.
Topics: China; Humans; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Uric Acid | 2022 |
Correlation between Glycated Haemoglobin Level, Cardiac Function, and Prognosis in Patients with Diabetes Mellitus Combined with Myocardial Infarction.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Myocardial Infarction; Natriu | 2022 |
Changes in Serum Uric Acid Level in Acute Myocardial Infarction Patients.
Topics: Bangladesh; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Humans; Myocardi | 2023 |
The association between serum uric acid and creatine phosphokinase in the general population: NHANES 2015-2018.
Topics: Creatine Kinase; Ethnicity; Female; Humans; Myocardial Infarction; Nutrition Surveys; Uric Acid | 2023 |
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study.
Topics: Cohort Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucose; Gout; Hospit | 2023 |
Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure.
Topics: Biomarkers; Heart Failure; HMGB1 Protein; Humans; Myocardial Infarction; Stroke Volume; Uric Acid; V | 2023 |
Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink.
Topics: Adult; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colchicine; Diarrhea; G | 2023 |
[Predictive value of hemoglobin to serum creatinine ratio combined with serum uric acid for in-hospital mortality after emergency percutaneous coronary intervention in patients with acute myocardial infarction].
Topics: Creatinine; Hospital Mortality; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; P | 2023 |
Serum uric acid is related to liver and kidney disease and 12-year mortality risk after myocardial infarction.
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Myocardial Infarction; Non-alcoholic Fat | 2023 |
Incorporating uric acid into the CHA2DS2-VASc score improves the prediction of new-onset atrial fibrillation in patients with acute myocardial infarction.
Topics: Atrial Fibrillation; Humans; Myocardial Infarction; Predictive Value of Tests; Retrospective Studies | 2023 |
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Hypertension; Italy; Male; Middle Aged; | 2020 |
The relationship between a combination of vitamin D deficiency and hyperuricemia and the severity of coronary artery disease in myocardial infarction patients.
Topics: Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; M | 2020 |
Serum Uric Acid Levels in Patients with Acute Myocardial Infarction and its Correlation with the Severity.
Topics: Humans; Myocardial Infarction; Uric Acid | 2020 |
A Study of the Serum Uric Acid Level as Prognostic Indicator in Acute Myocardial Infarction.
Topics: Humans; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Uric Acid; Ventricular D | 2020 |
Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Artery Disease; Female; Heart Failure; Humans; Hyperur | 2020 |
Associations between changes in serum uric acid and the risk of myocardial infarction.
Topics: Humans; Hypertension; Hyperuricemia; Middle Aged; Myocardial Infarction; Risk Factors; Uric Acid | 2020 |
Uric acid and risk of myocardial infarction. A dynamic duo.
Topics: Humans; Myocardial Infarction; Uric Acid | 2020 |
Lowered serum uric acid level may be associated with reduced risk of myocardial infarction.
Topics: Humans; Hyperuricemia; Myocardial Infarction; Uric Acid | 2020 |
[Related factors and the long-term outcome after percutaneous coronary intervention of premature acute myocardial infarction].
Topics: Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneou | 2020 |
Author's reply to: Lowered serum acid level may be associated with reduced risk of myocardial infarction.
Topics: Humans; Myocardial Infarction; Uric Acid | 2021 |
Elevated postoperative serum uric acid is associated with major adverse events following coronary artery bypass grafting.
Topics: Aged; Biomarkers; Coronary Artery Bypass; Coronary Artery Disease; Female; Hospital Mortality; Human | 2020 |
Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
Topics: Animals; Biomarkers; Caspase 3; Cell Hypoxia; Cells, Cultured; Disease Models, Animal; Hyperuricemia | 2021 |
Cumulative Serum Uric Acid and Its Time Course Are Associated With Risk of Myocardial Infarction and All-Cause Mortality.
Topics: Adult; Biomarkers; Cause of Death; China; Female; Humans; Hyperuricemia; Incidence; Male; Middle Age | 2021 |
Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
Topics: Adult; Atrial Fibrillation; Cardiovascular Diseases; Female; Heart Failure; Humans; Hyperuricemia; I | 2021 |
Association between Uric Acid and In-Hospital Heart Failure in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Topics: Aged; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary | 2021 |
Nutrition Status and Renal Function as Predictors in Acute Myocardial Infarction with and without Cancer: A Single Center Retrospective Study.
Topics: Aged; Female; Humans; Kidney; Logistic Models; Male; Middle Aged; Myocardial Infarction; Neoplasms; | 2021 |
Uric Acid Level Has a U-shaped Association with Clinical Outcomes in Patients with Vasospastic Angina.
Topics: Aged; Angina Pectoris; Body Mass Index; Calcium Channel Blockers; Coronary Angiography; Coronary Ves | 2017 |
Serum Uric Acid Could Differentiate Acute Myocardial Infarction and Unstable Angina Pectoris in Hyperuricemic Acute Coronary Syndrome Patients.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Diagnosis, Differential; Female; | 2017 |
The association between uric acid levels and different clinical manifestations of coronary artery disease.
Topics: Adult; Aged; Coronary Artery Disease; Coronary Vessels; Correlation of Data; Female; Humans; Male; M | 2018 |
Letter to the Editor: When Claiming a U-shaped Association between Uric Acid Levels and Major Adverse Cardiac Events, Perhaps Show the Evidence?
Topics: Heart; Humans; Hyperuricemia; Myocardial Infarction; Uric Acid | 2018 |
Is serum uric acid a pretty accurate prognostic predictor of ST elevated acute coronary syndrome?
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Humans; Myocardial Infarction; Prognosis; U | 2018 |
MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank.
Topics: Adult; Arthritis; Autoimmune Diseases; Biological Specimen Banks; Celiac Disease; Female; Genetic Pr | 2018 |
A relation of serum homocysteine, uric acid and C-reactive protein level in patients with acute myocardial infarction.
Topics: Aged; Atherosclerosis; Biomarkers; C-Reactive Protein; Female; Homocysteine; Humans; Hyperhomocystei | 2018 |
Hyperuricemia and smoking in young adults suspected of coronary artery disease ≤ 35 years of age: a hospital-based observational study.
Topics: Adolescent; Adult; Age of Onset; Beijing; Biomarkers; Coronary Artery Disease; Coronary Stenosis; Fe | 2018 |
Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population.
Topics: Asymptomatic Diseases; Biomarkers; Cause of Death; Cross-Sectional Studies; Electrocardiography; Fem | 2019 |
Theacrine attenuates myocardial fibrosis after myocardial infarction via the SIRT3/β-catenin/PPARγ pathway in estrogen-deficient mice.
Topics: Administration, Oral; Animals; Apoptosis; beta Catenin; Disease Models, Animal; Echocardiography; Es | 2019 |
Short-time variation in serum uric acid concentrations in post-myocardial infarction patients.
Topics: Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Uric Acid | 2013 |
Uric acid in-hospital changes predict mortality in patients with acute myocardial infarction.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Hospitalization; Humans; Logistic Models; Male; Midd | 2013 |
Hyperuricemia and cardiovascular disease: is this relationship independent of the etiology of hyperuricemia?
Topics: Angina, Unstable; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Renal Insufficie | 2013 |
Predictive value of serum uric acid levels on mortality in acute coronary syndrome patients with chronic kidney disease after drug-eluting stent implantation.
Topics: Aged; Angina, Unstable; Brain Diseases; China; Drug-Eluting Stents; Female; Glomerular Filtration Ra | 2013 |
Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet.
Topics: Animals; C-Reactive Protein; Cholesterol; Cholesterol, Dietary; Dietary Supplements; Hyperlipidemias | 2013 |
Uric acid level in patients with kidney disease.
Topics: Angina, Unstable; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Renal Insufficie | 2014 |
Uric Acid level should be stratified in order to better evaluate inflammatory status.
Topics: Angina, Unstable; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Renal Insufficie | 2014 |
Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
Topics: Age Factors; Contrast Media; Creatinine; Emergency Service, Hospital; Female; Glomerular Filtration | 2014 |
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascul | 2014 |
Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Topics: Aged; Biomarkers; Diabetic Nephropathies; Female; Humans; Hyperuricemia; Intraoperative Complication | 2014 |
The association between serum uric acid level and heart failure and mortality in the early period of ST-elevation acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; M | 2014 |
The association between serum uric acid level and heart failure and mortality in the early period of STEMI.
Topics: Female; Heart Failure; Humans; Male; Myocardial Infarction; Uric Acid | 2014 |
Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction.
Topics: Adult; Biomarkers; Blood Urea Nitrogen; Case-Control Studies; China; Cholesterol, HDL; Chromatograph | 2014 |
Novel predictors of infarct-related artery patency for ST-segment elevation myocardial infarction: Platelet-to-lymphocyte ratio, uric acid, and neutrophil-to-lymphocyte ratio.
Topics: Blood Platelets; Female; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Myocardial Infarc | 2015 |
Allopurinol use and risk of non-fatal acute myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Case-Control Studies; Female; Free Radical Scavengers; | 2015 |
Uric acid and mild renal impairment in patients with ST-elevation myocardial infarction.
Topics: Aged; Aged, 80 and over; Biomarkers; Female; Glomerular Filtration Rate; Humans; Hyperuricemia; Kidn | 2015 |
Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort.
Topics: Aged; Cohort Studies; Electrocardiography; Female; Humans; Hypertrophy, Left Ventricular; Italy; Mal | 2015 |
Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Female; Follow-Up Studies; Glomerular Filt | 2015 |
Ticagrelor-related gout: An underestimated side effect.
Topics: Adenosine; Gout; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Ticagrelor; Uri | 2015 |
Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Topics: Aged; Area Under Curve; Bilirubin; Biomarkers; C-Reactive Protein; Chi-Square Distribution; Female; | 2016 |
Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged, 80 and over; Blood Pressure; China; Coronary Angiography; Cystatin C; | 2015 |
Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary percutaneous coronary intervention.
Topics: Adult; Aged; Atrial Fibrillation; Blood Glucose; C-Reactive Protein; Creatinine; Erythrocyte Indices | 2016 |
What is the real predictive value of uric acid for mortality?
Topics: Female; Humans; Male; Myocardial Infarction; Renal Insufficiency; Uric Acid | 2016 |
Uric acid, an independent predictor of long-term mortality in ST-elevation myocardial infarction patients.
Topics: Female; Humans; Male; Myocardial Infarction; Renal Insufficiency; Uric Acid | 2016 |
Gender differences for uric acid as predictor of hard events in patients referred for coronary angiography.
Topics: Age Factors; Aged; Aged, 80 and over; Coronary Angiography; Female; Glomerular Filtration Rate; Huma | 2016 |
Effects of urate-lowering agents on arrhythmia vulnerability in post-infarcted rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Febuxostat; GAP-43 Protein; Male; Myocardial Infarction; Myocardium; | 2016 |
Mechanism-based pharmacokinetic-pharmacodynamic modeling of salvianolic acid A effects on plasma xanthine oxidase activity and uric acid levels in acute myocardial infarction rats.
Topics: Animals; Caffeic Acids; Chromatography, High Pressure Liquid; Lactates; Models, Biological; Myocardi | 2017 |
The association between serum uric acid and 1-year mortality in patients with ST-segment elevation myocardial infarction and chronic kidney disease: contrast-induced acute kidney injury and bleeding complications should be adjusted.
Topics: Acute Kidney Injury; Electrocardiography; Humans; Myocardial Infarction; Percutaneous Coronary Inter | 2016 |
[Association between the cardiovascular health score and new-onset atrial fibrillation].
Topics: Atrial Fibrillation; C-Reactive Protein; Humans; Incidence; Multivariate Analysis; Myocardial Infarc | 2016 |
Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Vessels; F | 2016 |
Association Between Hyperuricemia and Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction.
Topics: Adult; Aged; Cardiovascular Diseases; Diabetes Complications; Female; Heart Failure; Humans; Hyperte | 2017 |
The burden of major adverse cardiac events in patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Area Under Curve; Chi-Square Distribution; | 2017 |
Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data.
Topics: Adult; Electronic Health Records; Female; Gout; Heart Failure; Humans; Kidney Diseases; Male; Middle | 2017 |
Study of Serum Uric Acid Levels in Myocardial Infarction and Its Association With Killip Class.
Topics: Acute Disease; Aged; Analysis of Variance; Case-Control Studies; Echocardiography; Female; Heart Fai | 2017 |
The relationship between coronary artery disease and uric acid levels in young patients with acute myocardial infarction.
Topics: Adult; Antithrombin III; Body Mass Index; Coronary Angiography; Coronary Artery Disease; Creatinine; | 2008 |
Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience.
Topics: Aged; Biomarkers; Critical Care; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middl | 2010 |
Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats.
Topics: Adenosine Triphosphatases; alpha-Tocopherol; Animals; Antioxidants; Blood Proteins; Cell Membrane; C | 2008 |
Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Cardiotonic Ag | 2009 |
Uric acid levels for the prediction of prognosis in patients with acute ST elevation myocardial infarction: a new potential biomarker.
Topics: Biomarkers; Female; Hospital Mortality; Humans; Male; Myocardial Infarction; Predictive Value of Tes | 2010 |
Serum uric acid in acute myocardial infarction.
Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Electrocardiography; Female; Follow-Up Stud | 2008 |
Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Case-Control Studies; Herbal Medicine; H | 2009 |
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Confidence Intervals; Female; Heart Failure; Humans; Ma | 2009 |
I've been diagnosed with gout and told that the elevated level of uric acid that brought it about may also increase my risk of heart attack. Is this true?
Topics: Gout; Humans; Male; Myocardial Infarction; Risk Factors; Uric Acid | 2009 |
Serum uric acid for risk stratification of patients with coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged | 2009 |
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
Topics: Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; Female; Haptoglobins; Heart Failure; Humans; L | 2009 |
Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Croatia; Female; Hospitalization; Humans; Male; Middle A | 2009 |
Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study.
Topics: Animals; Ascorbic Acid; Biomarkers; Caffeic Acids; Isoproterenol; Lipid Peroxidation; Male; Myocardi | 2010 |
[Cardioprotective effects of activation of ATP-sensitive potassium channels in experiments in vivo: influence on blood biochemical parameters following ischemia-reperfusion of the myocardium].
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Dogs; Free Radicals; Hemodynamics | 2009 |
The association of serum uric acid levels with outcomes following percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Confidence Intervals; Coronary Artery Disease; | 2010 |
Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty.
Topics: Age Factors; Alanine Transaminase; Angioplasty; Arrhythmias, Cardiac; Aspartate Aminotransferases; D | 2010 |
Uric acid in the early risk stratification of ST-elevation myocardial infarction.
Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Cohort Studies; Confidence Intervals; | 2012 |
The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Creatinine; Diab | 2011 |
Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.
Topics: Adult; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Cholesterol; Heart | 2011 |
Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Topics: Adult; Aged; Angiography; Angioplasty, Balloon, Coronary; Electrocardiography; Female; Humans; Male; | 2011 |
Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Female; Humans; Kaplan-Meier Estimate; | 2011 |
Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients.
Topics: Adult; Aged; Albuminuria; C-Reactive Protein; Coronary Artery Disease; Creatinine; Cross-Sectional S | 2011 |
Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
Topics: Allopurinol; Analysis of Variance; Animals; Antioxidants; Atrasentan; Biomarkers; Cyclic N-Oxides; D | 2011 |
The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI.
Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Circulation; Female; Hospital Mor | 2011 |
Is γ-glutamyl transferase activity a potential marker of left ventricular function during early postmyocardial infarction period?
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Colorimetry; Creatine Kinase, MB Form; Dilatatio | 2011 |
Relationship of dyslipidemia and uric acid with the risk of myocardial infarction among hypertensive patients in Trinidad.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus, Type 2; Dyslipidemias; Fema | 2011 |
Correlation between the serum levels of uric acid and HS-CRP with the occurrence of early systolic failure of left ventricle following acute myocardial infarction.
Topics: C-Reactive Protein; Cross-Sectional Studies; Female; Heart Ventricles; Humans; Male; Myocardial Infa | 2011 |
Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Topics: Age Factors; Angioplasty, Balloon, Coronary; Diabetes Mellitus; Female; Follow-Up Studies; Heart Fai | 2012 |
Different independent susceptibility markers for first-ever cerebral infarction and myocardial infarction in young patients.
Topics: Adolescent; Adult; Alcohol Drinking; Blood Urea Nitrogen; Brain; Cerebral Infarction; Chi-Square Dis | 2012 |
Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cause of Death; Coronary Artery Disease; Co | 2012 |
Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
Topics: Aged; Aged, 80 and over; Allopurinol; C-Reactive Protein; Colchicine; Female; Gout; Gout Suppressant | 2012 |
Protective efficacy of ellagic acid on glycoproteins, hematological parameters, biochemical changes, and electrolytes in myocardial infarcted rats.
Topics: Animals; Blood Glucose; Blood Proteins; Cardiotonic Agents; Electrolytes; Ellagic Acid; Glycoprotein | 2012 |
Preconditioning protects the heart in a prolonged uremic condition.
Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, M | 2012 |
Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Topics: Adult; Aged; Contrast Media; Coronary Angiography; Female; Humans; Kidney Diseases; Male; Middle Age | 2014 |
On-admission serum uric acid predicts outcomes after acute myocardial infarction.
Topics: Humans; Myocardial Infarction; Patient Admission; Uric Acid | 2012 |
Uric acid for diagnosis and risk stratification in suspected myocardial infarction.
Topics: Aged; Biomarkers; Early Diagnosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxidati | 2013 |
[Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Circulation; Female; Humans; Male; Middle Aged; Myoca | 2012 |
The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid?
Topics: Antihypertensive Agents; Cardiotonic Agents; Diuretics; Humans; Hypertension; Hypolipidemic Agents; | 2002 |
Hyperuricemia; relationship to hypercholesteremia and acute myocardial infarction.
Topics: Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Cholesterol; Humans; Hypercholesterole | 1959 |
Hyperuricemia in myocardial infarction.
Topics: Cardiovascular Diseases; Humans; Hyperuricemia; Myocardial Infarction; Uric Acid | 1961 |
Serum uric acid in myocardial infarction.
Topics: Cardiovascular Diseases; Humans; Myocardial Infarction; Probenecid; Uric Acid | 1963 |
CORONARY ARTERY DISEASE IN NATAL INDIANS.
Topics: Aspartate Aminotransferases; Blood Chemical Analysis; Blood Pressure Determination; Cholesterol; Cor | 1964 |
Reduction of serum-lipid and uric-acid levels by an orally active androsterone.
Topics: Androgens; Androsterone; Cholesterol; Hormone Replacement Therapy; Humans; Lipids; Myocardial Infarc | 1962 |
[Behavior and prognostic significance of alterations of uric acid blood levels in myocardial infarct].
Topics: Blood; Humans; Myocardial Infarction; Myocardium; Prognosis; Uric Acid | 1950 |
The European Society of Cardiology working group on heart failure: Heart Failure Update 2003.
Topics: Carbazoles; Cardiac Pacing, Artificial; Carvedilol; Eplerenone; Europe; Heart Failure; Humans; Metop | 2003 |
Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).
Topics: Aged; Biomarkers; Coronary Angiography; Creatine Kinase; Electrocardiography; Female; Follow-Up Stud | 2005 |
Clinical trials of uric acid lowering for coronary heart disease risk reduction.
Topics: Clinical Trials as Topic; Coronary Disease; Humans; Hyperuricemia; Myocardial Infarction; Platelet A | 2006 |
Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study.
Topics: Aged; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Cerebral Hemorrhage; Cohort Stu | 2006 |
Prognostic significance of serum uric acid in acute myocardial infarction.
Topics: Humans; Myocardial Infarction; Prognosis; Severity of Illness Index; Uric Acid | 2006 |
Uric acid in patients with angiographically documented coronary heart disease.
Topics: Age Factors; Aged; Biomarkers; Cholesterol, HDL; Coronary Angiography; Coronary Disease; Coronary St | 2006 |
Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study.
Topics: Animals; Benzothiazoles; Biphenyl Compounds; Blood Glucose; Ca(2+) Mg(2+)-ATPase; Calcium-Transporti | 2007 |
Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Artery Disease; Female; Genetic Predi | 2008 |
[Experiences with ethacrynic acid, a new diuretic].
Topics: Creatine; Edema; Ethacrynic Acid; Glycosuria; Heart Failure; Humans; Liver Function Tests; Myocardia | 1966 |
Distribution patterns of uric acid in coronary artery disease.
Topics: Coronary Disease; Humans; Myocardial Infarction; Sex; Uric Acid | 1967 |
Correlations of serum uric acid and lipid concentrations in normal, gouty, and atherosclerotic men.
Topics: Adult; Arteriosclerosis; Black or African American; Blood Donors; Cholesterol; Ethnology; Female; Gl | 1967 |
Myocardial infarction and individual characteristics. Clinical manifestations.
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Body Height; Body Weight; Cholesterol; Educa | 1967 |
[Blood levels of cholesterol, glucose and uric acid and oscillometric studies on lower limbs in patients with past myocardial infarction].
Topics: Aged; Arteriosclerosis; Blood Glucose; Cholesterol; Female; Humans; Male; Middle Aged; Myocardial In | 1967 |
The coronary profile: 12-year follow-up in the Framingham study.
Topics: Age Factors; Angina Pectoris; Blood Pressure; Cholesterol; Coronary Disease; Death, Sudden; Diabetes | 1967 |
Coincidence of cerebrovascular accident and silent myocardial infarction.
Topics: Adult; Arterial Occlusive Diseases; Bundle-Branch Block; Cardiomegaly; Cerebral Angiography; Cerebra | 1982 |
[A longitudinal study of secondary prevention of heart infarct].
Topics: Aftercare; Aged; Blood Glucose; Female; Humans; Hyperlipidemias; Hypertension; Longitudinal Studies; | 1983 |
The management of hyperuricaemia.
Topics: Adult; Aged; Follow-Up Studies; Gout; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myoc | 1984 |
Risk factor modification in the framework of rehabilitation. Results of a long-term rehabilitation program in Bavaria.
Topics: Cholesterol; Exercise Therapy; Germany, West; Humans; Hypertension; Long-Term Care; Myocardial Infar | 1982 |
Metabolic studies in postmyocardial infarction patients.
Topics: Blood Glucose; Cholesterol; Diet; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Myocar | 1982 |
Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents.
Topics: Adult; Antihypertensive Agents; Chemical Phenomena; Chemistry; Chlorthalidone; Diuretics; Humans; Hy | 1983 |
[Glycide tolerance and its relationships after myocardial infarct].
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; Insulin; L | 1980 |
Erythrocyte sedimentation rate and cardiovascular disease. Results from a population study of women in Göteborg, Sweden.
Topics: Adult; Angina Pectoris; Blood Sedimentation; Cardiovascular Diseases; Cerebrovascular Disorders; Cho | 1982 |
Critical evaluation of serum uric acid levels in acute myocardial infarction.
Topics: Aged; Female; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Risk; Sex F | 1982 |
[The serum uric acid level in the Viennese population (author's transl)].
Topics: Adult; Age Factors; Austria; Blood Glucose; Body Weight; Diabetes Mellitus; Female; Gout; Health Sur | 1981 |
Body weight change in relation to incidence of ischemic heart disease and change in risk factors for ischemic heart disease.
Topics: Adult; Aged; Angina Pectoris; Blood Glucose; Blood Pressure; Body Weight; Coronary Disease; Diabetes | 1980 |
[Study of associated risk factors and prevalence of heart diseases in patients with arterial hypertension].
Topics: Aged; Alcohol Drinking; Atrial Fibrillation; Coronary Disease; Data Interpretation, Statistical; Dia | 1995 |
A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases.
Topics: Adult; Allantoin; Creatine Kinase; Female; Humans; Hypoxanthine; Hypoxanthines; Isoenzymes; Male; My | 1994 |
[Concurrent and predictive correlations between emotions and cardiovascular and metabolic parameters in patients with myocardial infarct].
Topics: Arousal; Blood Pressure; Emotions; Heart Rate; Humans; Lipids; Male; Middle Aged; Myocardial Infarct | 1993 |
Effectiveness of thrombolysis is associated with a time-dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction.
Topics: Adenosine; Chromatography, High Pressure Liquid; Female; Free Radicals; Humans; Hypoxanthine; Hypoxa | 1993 |
Assessment of radical activity during the acute phase of myocardial infarction following fibrinolysis: utility of assaying plasma malondialdehyde.
Topics: Aged; beta Carotene; Carotenoids; Chromatography, High Pressure Liquid; Female; Fibrinolysis; Free R | 1995 |
Serum total antioxidant activity after myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Female; Humans; Male; Middle Aged; Myocardial Infarcti | 1997 |
Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors.
Topics: Adult; Aged; Anthropometry; Blood Glucose; Blood Pressure; C-Peptide; Comorbidity; Convalescence; Co | 1997 |
Serum urate and the risk of major coronary heart disease events.
Topics: Adult; Biomarkers; Cholesterol; Coronary Artery Disease; Coronary Disease; Humans; Male; Middle Aged | 1997 |
Serum antioxidant activity after myocardial infarction.
Topics: Antioxidants; Humans; Myocardial Infarction; Reproducibility of Results; Serum Albumin; Uric Acid | 1998 |
Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs.
Topics: Adenine Nucleotides; Adenosine; Animals; Benzopyrans; Dihydropyridines; Dogs; Extracellular Space; H | 1998 |
Serum uric acid levels in cardiovascular diseases.
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; Lipoproteins; Male; M | 1998 |
Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases.
Topics: Cardiovascular Diseases; Cause of Death; Cohort Studies; Germany; Humans; Male; Middle Aged; Mortali | 1999 |
[Level of blood uric acid in patients with postinfarction heart failure].
Topics: Acid-Base Equilibrium; Adult; Aged; Carbon Dioxide; Heart Failure; Humans; Hydrogen-Ion Concentratio | 2000 |
[Malonyldialdehyde, uric acid and white cell count as markers of oxidative stress in acute myocardial infarction and acute coronary insufficiency].
Topics: Adult; Aged; Biomarkers; Female; Humans; Leukocyte Count; Lipid Peroxidation; Male; Malondialdehyde; | 2001 |
[Uric acid content in coronary atherosclerosis and hypertensive disease].
Topics: Adult; Arteriosclerosis; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Middle Aged; Myocard | 1976 |
[The relationship of uric acid, triglycerides, and cholesterol].
Topics: Adult; Aged; Cholesterol; Gout; Humans; Middle Aged; Myocardial Infarction; Triglycerides; Uric Acid | 1978 |
Analysis of the components of CHD risk in the Framingham study: new multivariate procedures for the analysis of chronic disease development.
Topics: Age Factors; Angina Pectoris; Blood Pressure; Cholesterol; Chronic Disease; Coronary Disease; Diasto | 1979 |
[Various mechanisms of disorders of carbohydrate metabolism in myocardial infarct].
Topics: Acute Disease; Adult; Aged; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin | 1979 |
Prognostic value of serum uric acid in patients of acute myocardial infarction.
Topics: Adult; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Uric Acid | 1977 |
[Studies on late mortality of myocardial infarct. Part II].
Topics: Adult; Age Factors; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Follow-Up Studies; Germa | 1977 |
Allopurinol-induced myocardial and renal damage in nonarteriosclerotic (virgin) and arteriosclerotic (breeder) Sprague-Dawley rats.
Topics: Allopurinol; Animals; Arteriosclerosis; Blood Glucose; Blood Urea Nitrogen; Breeding; Corticosterone | 1978 |
[Changes in uricemia in acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Blood Glucose; Creatinine; Female; Humans; Male; Middle | 1978 |
[Myocardial infarction: comparative study of principal risk factors in the two sexes].
Topics: Adult; Age Factors; Aged; Blood Glucose; Female; France; Humans; Hyperlipidemias; Hypertension; Lipi | 1976 |
[Conclusions from a clinical study of myocardial infarction in young men under 40 years of age].
Topics: Adult; Age Factors; Death, Sudden; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle Aged; M | 1977 |
Hyperuricemia as a risk factor in coronary heart disease.
Topics: Age Factors; Black People; Coronary Disease; Female; Gout; Humans; Male; Myocardial Infarction; Sex | 1977 |
[Myocardial infarct in men under 40 years of age].
Topics: Adult; Age Factors; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarc | 1977 |
Renal stones and coronary heart disease.
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Glucose Tolerance Test; Humans; Kidney Calculi; Lipid | 1976 |
Relationship of plasma uric acid to plasma lipids and lipoproteins in subjects with peripheral vascular disease.
Topics: Body Weight; Cholesterol; Coronary Disease; Female; Humans; Lipoproteins; Male; Middle Aged; Myocard | 1976 |
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases.
Topics: Adult; Cholesterol; Coronary Disease; Female; Heterozygote; Humans; Hypercholesterolemia; Hypertensi | 1976 |
Uraemia and hyperuricaemia in acute myocardial infarction.
Topics: Acute Disease; Creatinine; Humans; Male; Myocardial Infarction; Urea; Uremia; Uric Acid | 1976 |
[Hyperuricaemia and stenotic coronary atherosclerosis. A description of 214 recent cases of myocardial infarction (author's transl)].
Topics: Adult; Aged; Carbohydrate Metabolism; Coronary Disease; Female; Humans; Hyperlipidemias; Male; Metab | 1976 |
[Uric acid concentration in serum in different types of hyperlipoproteinemia, myocardial infarction and primary gout].
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Glucose Tolerance Test; Gout; Humans; Hyperlipidemi | 1975 |
Uric acid kinetic studies in the immediate post-myocardial-infarction period.
Topics: Body Weight; Carbon Radioisotopes; Creatinine; Humans; Kinetics; Lactates; Male; Metabolic Clearance | 1975 |
Myocardial infarction in young men. Study of risk factors in nine countries.
Topics: Adult; Australia; Body Weight; Cholesterol; Coronary Disease; Diabetes Complications; Germany, West; | 1975 |
Changes in plasma urate concentration immediately after acute myocardial infarction.
Topics: Aspartate Aminotransferases; Coronary Disease; Humans; Myocardial Infarction; Time Factors; Uric Aci | 1975 |
[Latent diabetes mellitus as a risk factor in myocardial infarct].
Topics: Adult; Aged; Diabetes Complications; Humans; Hypercholesterolemia; Hypertension; Middle Aged; Myocar | 1975 |
Liaison psychiatry on a coronary care unit.
Topics: Adaptation, Psychological; Adult; Ambulatory Care; Cholesterol; Coronary Care Units; Female; Humans; | 1975 |
Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanisms for free radical generation.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Coronary | 1991 |
Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study.
Topics: Adolescent; Adult; Age Factors; Black People; Cardiovascular Diseases; Child; Child, Preschool; Chol | 1991 |
Coronary risk factors in newly diagnosed and previously diagnosed type 2 diabetic men with myocardial infarction.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Di | 1991 |
[Current findings on nocturnal catecholamine excretion in coronary patients].
Topics: Adult; Aged; Catecholamines; Cholesterol; Circadian Rhythm; Epinephrine; Humans; Male; Middle Aged; | 1990 |
Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction.
Topics: Adult; Apolipoproteins; Blood Glucose; Blood Pressure; China; Coronary Disease; Female; Humans; Lipi | 1990 |
Serum uric acid in ischemic heart disease.
Topics: Adult; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Risk; Uric Acid | 1986 |
Preventive cardiology for coronary artery disease.
Topics: Cholestyramine Resin; Combined Modality Therapy; Coronary Disease; Humans; Hyperlipidemias; Hyperten | 1985 |
Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study.
Topics: Age Factors; Analysis of Variance; Antihypertensive Agents; Blood Glucose; Coronary Disease; Female; | 1985 |
[Uric acid metabolism in the acute period of myocardial infarct].
Topics: Adult; Aged; Female; Humans; Kidney; Male; Middle Aged; Myocardial Infarction; Time Factors; Uric Ac | 1985 |
[Lipid peroxidation in the evaluation of healing of myocardial infarction].
Topics: Adult; Aged; Female; Humans; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Myocardial Infarct | 1985 |
[Risk factors in acute myocardial infarct and cerebral ischemic disease].
Topics: Adult; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Cholesterol, HDL; Electrocardiograp | 1985 |
[Changes in the metabolic parameters in patients with acute myocardial infarct in the course of the rehabilitation phase II].
Topics: Adult; Aged; Blood Glucose; Cholesterol; Energy Metabolism; Female; Humans; Lactates; Lactic Acid; L | 1985 |
Serum uric acid, urea nitrogen and creatinine levels in acute myocardial infarction.
Topics: Adult; Aged; Blood Urea Nitrogen; Creatinine; Female; Humans; Male; Middle Aged; Myocardial Infarcti | 1985 |
White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction.
Topics: Adult; Aged; Aspirin; Cholesterol; Coronary Disease; Dipyridamole; Diuretics; Female; Hematocrit; Hu | 1985 |
Transcortin activity as related to the age at discovery of diabetes mellitus.
Topics: Adult; Age Factors; Aged; Alpha-Globulins; Beta-Globulins; Blood Glucose; Blood Proteins; Body Heigh | 1970 |
[Ist results of a prospective survey on cardiovascular diseases in a large enterprise].
Topics: Adult; Age Factors; Angina Pectoris; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; France; | 1973 |
Profile for long-term survival after myocardial infarction.
Topics: Adult; Arterial Occlusive Diseases; Blood Pressure; Body Weight; Cardiomegaly; Cholesterol; Diet The | 1973 |
Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipo | 1973 |
[Coronaropathies in the black African. Clinical, etiological and current epidemiological aspects (apropos of 45 cases)].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Black People; Coronary Disease; Cote d'Ivoire; Diabetes C | 1974 |
Short-term group psychotherapy for post-myocardial infarction patients and their wives.
Topics: Adaptation, Psychological; Anxiety; Blood Pressure; Cholesterol; Conflict, Psychological; Electrocar | 1968 |
[Relationship between uric acid and infarction of the myocardium (author's transl)].
Topics: Female; Humans; Male; Myocardial Infarction; Uric Acid | 1974 |
[Effects of coffee during good health and in disease from the medical standpoint].
Topics: Acute Disease; Aged; Blood Pressure; Caffeine; Cerebrovascular Disorders; Coffee; Diabetes Mellitus; | 1974 |
Serum uric acid in coronary heart disease.
Topics: Adult; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Uric | 1974 |
The health of leaders and policy-makers.
Topics: Adult; Aged; Coronary Disease; Gout; Heart Diseases; Humans; Leadership; Longevity; Male; Middle Age | 1972 |
Recognition of myocardial infarction after cardiac surgery and its relation to cardiopulmonary bypass.
Topics: Alanine Transaminase; Angiography; Arrhythmias, Cardiac; Aspartate Aminotransferases; Cardiac Cathet | 1974 |
[Blood uric acid levels in myocardial infarction].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Uric Acid | 1972 |
[Hyperuricemia and myocardial infarct].
Topics: Arteriosclerosis; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercholesterolem | 1972 |
[Prognosis and prevention of gout complications].
Topics: Adult; Aged; Arteriosclerosis; Diseases in Twins; Female; Gout; Humans; Kidney Calculi; Kidney Disea | 1972 |
[Hyperlipidemia and other risk factors in coronary sclerosis].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Complications; Glucose Tolerance Test; Humans; | 1972 |
Risk factors in coronary heart disease: possibilities of prevention in the Federal Republic of West Germany.
Topics: Age Factors; Body Weight; Cholesterol; Diabetes Complications; Europe; Female; Germany, West; Hepari | 1972 |
Serum lipids, serum uric acid and glucose tolerance in coronary heart disease.
Topics: Adult; Angina Pectoris; Blood Glucose; Cholesterol; Coronary Disease; Female; Glucose Tolerance Test | 1973 |
Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Blood Glucose; Cholesterol; Coronary Disease; Female; Fo | 1973 |
Long-term treatment of patients with abnormal intravenous glucose tolerance after myocardial infarction.
Topics: Cholesterol; Evaluation Studies as Topic; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test | 1973 |
Metabolic features of Johannesburg Bantu with myocardial infarction.
Topics: Adult; Aged; Arteriosclerosis; Black or African American; Black People; Blood Glucose; Fasting; Fema | 1973 |
[The aetiology of myocardial infarction in young people (author's transl)].
Topics: Adult; Age Factors; Contraceptives, Oral; Female; Humans; Infections; Male; Metabolic Diseases; Myoc | 1973 |
Raised serum uric acid levels with myocardial infarction.
Topics: Acute Disease; Adult; Aged; Colorimetry; Female; Humans; Male; Middle Aged; Myocardial Infarction; U | 1974 |
Uric acid metabolism following acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Body Weight; Carbon Radioisotopes; Creatinine; Crystallization; Humans; | 1974 |
Outpatient gym exercise program for patients with recent myocardial infarction. A preliminary report.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Electrocardiography; Evaluatio | 1974 |
Metabolic aspects of physical training in male patients after myocardial infarction.
Topics: Administration, Oral; Blood Glucose; Body Weight; Cholesterol; Glucose; Glucose Tolerance Test; Huma | 1974 |
Retrospective study of men who had undergone myocardial infarction at the age of 40 years or younger.
Topics: Adult; Age Factors; Aged; Aging; Angina Pectoris; Arteriosclerosis; Blood Glucose; Blood Pressure; C | 1974 |
Letter: Serum uric acid and myocardial infarction.
Topics: Adult; Female; Humans; Male; Myocardial Infarction; Sex Factors; Uric Acid | 1974 |
Thyroid and steroid hormones and metabolic parameters in myocardial infarction.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Blood Glucose; Female; Glucocorticoids; Humans; L | 1969 |
Comparisons of serum lipid and uric acid content in white and Negro men.
Topics: ABO Blood-Group System; Adult; Black or African American; Cholesterol; Culture; Diet; Gout; Humans; | 1970 |
[Hyperuricemia in myocardial infarct].
Topics: Adult; Aged; Cholesterol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Triglycerides; U | 1972 |
[Missed gout].
Topics: Arteriosclerosis; Arthritis, Rheumatoid; Diagnosis, Differential; Gout; Humans; Hypertension; Kidney | 1972 |
Hyperuricaemia and myocardial infarction.
Topics: Female; Gout; Humans; Male; Middle Aged; Myocardial Infarction; Uric Acid | 1972 |
Mass health examinations in the Busselton population, 1966 to 1970.
Topics: Adult; Aged; Australia; Blood Glucose; Blood Pressure; Cerebrovascular Disorders; Child; Cholesterol | 1972 |
[Metabolism of lipids and uric acid in experimental and normal stress].
Topics: Adult; Aged; Cholesterol; Creatinine; Epinephrine; Fatty Acids, Nonesterified; Humans; Lipid Metabol | 1971 |
[Usability of the discriminant analysis technic in epidemiologic studies of coronary disease].
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Epidemiologic Methods; Factor Analysis, Statistical | 1971 |
Acute myocardial infarction in a 21-year-old male with normal selective coronary arteriogram.
Topics: Adult; Angiocardiography; Aspartate Aminotransferases; Blood Protein Electrophoresis; Electrocardiog | 1971 |
Early and late observations after acute myocardial ischaemic episodes with particular reference to glucose tolerance.
Topics: Cholesterol; Fatty Acids, Nonesterified; Follow-Up Studies; Glucose Tolerance Test; Humans; Male; Mi | 1968 |
Coronary heart disease in male twins. Hereditary and environmental factors in concordant and discordant pairs.
Topics: Adult; Aged; Angina Pectoris; Autopsy; Blood Pressure; Body Height; Body Weight; Cholesterol; Confli | 1970 |
Adverse clinical side effects of levodopa therapy.
Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Ede | 1971 |
Platelet aggregation in several cardiovascular diseases determined with a modified screen filtration pressure method.
Topics: Adenine Nucleotides; Adolescent; Adult; Blood Platelets; Cardiovascular Diseases; Cell Aggregation; | 1970 |
[Serum uric acid levels of 113 patients following heart infarct].
Topics: Adult; Autoanalysis; Humans; Male; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Uric A | 1969 |
Myocardial infarction in Johannesburg Bantu.
Topics: Adult; Age Factors; Aged; Black People; Blood Pressure; Body Constitution; Diet; Female; Hospitaliza | 1970 |
Carbohydrate, insulin, and lipid interrelationship in ischemic vascular disease.
Topics: Age Factors; Aged; Angina Pectoris; Blood Glucose; Blood Pressure; Body Height; Body Weight; Coronar | 1970 |
[Purine metabolism and coronary diseases. Biochemical findings and etiopathological considerations].
Topics: Adult; Arteritis; Coronary Disease; Female; Humans; Kidney Tubules; Lactates; Male; Middle Aged; Myo | 1970 |
Inter-relationship of serum uric acid and serum cholesterol in cases of coronary artery disease.
Topics: Cholesterol; Coronary Disease; Humans; Myocardial Infarction; Uric Acid | 1970 |
[Results of a comparative cross section study of healthy persons and patients with circulatory disorders in longitudinal epidemiological studies].
Topics: Adult; Age Factors; Blood Sedimentation; Body Height; Body Weight; Cholesterol; Electrocardiography; | 1970 |
[Serum lipids and uric acid values in 177 occasional blood donors and 116 post-infarction patients].
Topics: Adult; Blood Donors; Cholesterol; Fatty Acids; Fatty Acids, Nonesterified; Humans; Lipids; Male; Mid | 1970 |
[Current problems of gout].
Topics: Blood Glucose; Cholesterol; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercho | 1970 |
Interaction between psychic and somatic risk factors of myocardial infarction.
Topics: Adult; Cholesterol; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Persona | 1970 |
The aetiology and possible prevention of myocardial infarction.
Topics: Adult; Age Factors; Aged; Calcium; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperten | 1971 |
An unusual form of renal disease associated with gout and hypertension.
Topics: Adolescent; Adult; Aged; Biopsy; Cerebrovascular Disorders; Chromosome Aberrations; Chromosome Disor | 1971 |
Role of kidney in producing hyperuricaemia in acute myocardial infarction.
Topics: Acute Disease; Humans; Kidney; Kidney Function Tests; Myocardial Infarction; Uric Acid | 1971 |
Cineangiography of the coronary arteries: clinical function and anatomic correlation in patients with chronic chest pain.
Topics: Adult; Age Factors; Angina Pectoris; Arteries; Blood Pressure; Cardiac Catheterization; Cardiac Outp | 1971 |
[Level of cholesterol, triglycerides and uric acid in blood and urinary excretion of 17-hydroxy-corticoids in recent myocardial infarction].
Topics: 17-Hydroxycorticosteroids; Adult; Aged; Cholesterol; Female; Humans; Male; Middle Aged; Myocardial I | 1967 |
[The BBC study. Applied epidemiology of ischemic heart diseases].
Topics: Adult; Body Weight; Caffeine; Cholesterol; Coronary Disease; Epidemiologic Methods; Hematocrit; Huma | 1967 |
Serum cholesterol, triglyceride and uric acid levels as well as urinary 17-hydroxycorticosteroid excretion in cases of recent myocardial infarction.
Topics: 17-Hydroxycorticosteroids; Adult; Aged; Cholesterol; Female; Humans; Male; Middle Aged; Myocardial I | 1968 |
Incidence, pattern and mechanism of transient hyperuricemia in patients with acute myocardial infarction.
Topics: Aged; Humans; Middle Aged; Myocardial Infarction; Purines; Stress, Physiological; Uric Acid | 1968 |
Serum uric acid and serum cholesterol relationship in acute myocardial infarction.
Topics: Cholesterol; Humans; Middle Aged; Myocardial Infarction; Uric Acid | 1968 |
[Transitory hyperuricemia during acute myocardial infarct and acute vascular cerebropathy].
Topics: Acute Disease; Cerebrovascular Disorders; Humans; Myocardial Infarction; Uric Acid | 1968 |
The interpretation of radioactive uric acid turnover data.
Topics: Arthritis, Rheumatoid; Biological Assay; Carbon Isotopes; Gout; Humans; Hypertension; Myocardial Inf | 1968 |
Blood uric acid and serum enzymes relationship in acute myocardial infarction.
Topics: Aspartate Aminotransferases; Humans; Myocardial Infarction; Uric Acid | 1969 |
Myocardial infarction in early age. 3. Coronary risk factors and their deficient control.
Topics: Adult; Age Factors; Blood Glucose; Blood Pressure; Body Height; Body Weight; Cholesterol; Diet Thera | 1969 |
A study of serum uric acid in myocardial infarction and "angina of effort".
Topics: Angina Pectoris; Blood; Humans; Myocardial Infarction; Uric Acid | 1965 |
[The infarct profile. Differences between infarct patients and control subjects in Eastern Switzerland].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Arthritis; Body Height; Body Weight; Cholesterol; Diabete | 1966 |
A comparison of platelet stickiness tests during an atromid-S trial.
Topics: Adenine Nucleotides; Adult; Androsterone; Anticholesteremic Agents; Blood Coagulation Tests; Blood P | 1966 |
[New results in epidemiological research in ischemic heart disease. I. Retrospective epidemiological observation: alcohol consumption of infarct patients. II. Prospective epidemiological observation: the EKG before and after infarct--the EKG in population
Topics: Adult; Alcoholism; Arteriosclerosis; Cholesterol; Diet, Atherogenic; Electrocardiography; Epidemiolo | 1966 |